US20060200319A1 - System and method for identifying disease-influencing genes - Google Patents
System and method for identifying disease-influencing genes Download PDFInfo
- Publication number
- US20060200319A1 US20060200319A1 US11/359,437 US35943706A US2006200319A1 US 20060200319 A1 US20060200319 A1 US 20060200319A1 US 35943706 A US35943706 A US 35943706A US 2006200319 A1 US2006200319 A1 US 2006200319A1
- Authority
- US
- United States
- Prior art keywords
- individuals
- queries
- server
- individual
- responses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
- A61B5/6896—Toys
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/30—Data warehousing; Computing architectures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/40—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0443—Modular apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/087—Measuring breath flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
Definitions
- This invention relates generally to the fields of genomics, bioinformatics, and drug development. More specifically, it relates to a database containing phenotypic and environmental data on groups of individuals for use in conjunction with gene sequences to identify disease-influencing genes and substances.
- Genes are comprised of DNA, which in turn consists of four nucleotides known as adenine (A), thymine (T), cytosine (C), and guanine (G).
- a particular series of nucleotides is known as a gene sequence.
- Each gene sequence codes for a protein.
- a defective or mutant gene sequence will not produce a working protein.
- the protein may not perform its purpose, the protein may carry out a different purpose than intended, too much protein may be made, too little protein may be made, or the protein may not be made at all. If the protein is essential to one or more functions of the body, disease will result.
- Mutant gene sequences are either inherited or acquired. An inherited gene sequence is received from an individual's parents, while an acquired gene sequence results from an event in the individual's lifetime which changes the original gene sequence.
- a classic example of an inherited mutant gene sequence is the sickle cell anemia gene.
- Sickle cell anemia is caused by the substitution of a single nucleotide (A to T) in the gene sequence of an individual. This single substitution results in the substitution of a single amino acid (glutamic acid to valine) in the resulting hemoglobin protein.
- the mutant hemoglobin protein produces crescent-shaped or sickled red blood cells in affected individuals, causing a decrease in the amount of oxygen that can be transported throughout the body. The lack of oxygen often results in kidney and heart failure, paralysis, and rheumatism, which are common symptoms of anemic individuals.
- malignant melanoma or skin cancer.
- Cancer results when normal cells in an individuals body either lose or gain certain functions, resulting in the unchecked growth of non-normal cells. These non-normal cells often form tumors and spread throughout the body, disrupting normal cell functions.
- a cancer such as malignant melanoma is caused when the original gene sequence in epidermal cells is changed or mutated by an environmental factor, such as UV radiation.
- Our cells contain repair mechanisms to fix such problems, but over time the gene sequences in epidermal cells acquire more and more mutations. Mutant proteins are then produced and cellular functions are disrupted. The individual then has skin cancer.
- Another factor that should be considered when discussing genetic diseases is whether they are monogenic or polygenic in nature.
- Sickle cell anemia and cystic fibrosis are examples of monogenic diseases, as they are caused by a single gene sequence.
- Most types of cancer, asthma, and diabetes are examples of polygenic diseases, as they are caused by a variety of genes.
- Polygenic diseases are also more likely to be influenced by an individual's environment. Not surprisingly, polygenic diseases are more difficult to diagnose and treat. Thus, the use of gene sequences in developing new drugs is dependent the monogenic or polygenic nature of genetic diseases.
- Genomics companies can typically be classified into one of two groups.
- the first group concentrates on gene sequencing in order to find both drug targets and drug candidates, usually in the form of proteins expressed by the gene sequences.
- Gene sequencing can either be in the form of random, discovery, whereby genes are sequenced without regard to their functions, or in the form of targeted discovery, whereby a certain region of the genome which is tentatively associated with a disease is sequenced.
- random discovery gene sequencing potentially useful gene sequences are identified and assayed to determine if they can be used in drug development.
- One problem with random discovery gene sequencing is that the majority of the human genome contains introns, or gene sequences which do not code for proteins.
- sequence complementary DNA (cDNA) instead.
- cDNA is produced from messenger RNA (mRNA).
- mRNA messenger RNA
- mRNA messenger RNA
- mRNA messenger RNA
- mRNA messenger RNA
- mRNA messenger RNA
- mRNA messenger RNA
- mRNA is transcribed from DNA and processed by certain enzymes which remove the introns. cDNA sequence
- Targeted discovery gene sequencing is typically used with positional cloning, comparative gene expression, and functional cloning techniques, which are described in the next group.
- the second group of genomics companies takes a more epidemiological approach by first researching families or groups of individuals having a similar disease, and then isolating the relevant genes.
- this method also known as positional cloning, blood samples are taken from the individuals and analyzed.
- the blood samples contain DNA, which is studied to identify certain regions of the genome which appear to be associated with the disease. Linking a region of the genome with a disease is known as linkage analysis or genetic linkage mapping. Once a region of the genome has been identified, it is sequenced via targeted discovery gene sequencing.
- the second group of genomics companies also uses comparative gene expression to discover disease gene sequences.
- comparative gene expression mRNA from both healthy and diseased tissue is isolated. The mRNA is then used to produce cDNA, which is sequenced using targeted discovery gene sequencing. The gene sequences from both the healthy and diseased tissue are then compared.
- the identification of genes associated with disease can be made by studying the level of expression of genes in both the healthy and diseased tissue.
- Another similar technique is functional cloning. Mutant or non-functional proteins in metabolic pathways are studied and identified. The proteins are sequenced using targeted discovery gene sequencing and these sequences are used to figure out the corresponding DNA gene sequences. Once the disease gene sequences have been identified, they can be used in drug development.
- Incyte pharmaceuticals (Palo Alto, Calif.). Incyte uses random discovery gene sequencing to produce its LifeSeqTM and LifeSeq FLTM databases. These databases contain the sequences of hundreds of human genes. These databases are licensed to drug development companies who use the sequences to produce new drugs. Databases covering animals (ZooSeqTM), plants (PhytoSeqTM), and bacteria and fungi (PathoSeqTM) are also available. Incyte has also developed bioinformatics software, which provides sequence analysis and data management for their databases. In addition, Incyte offers cDNA libraries of the gene sequences in their databases, which can be directly used in drug development.
- HGS Human Genome Sciences (Rockville, Md.) also concentrates on random discovery gene sequencing, and has sequenced an estimated 90% of the 100,000 genes in the human body. In addition to collaborating with drug development companies who use their gene sequences, HGS also has its own drug discovery and development division. A number of therapeutic proteins which appear effective in animal models are under study.
- HySeq, Inc. (Sunnyvale, Calif.) has its HyX Platform which is capable of processing and sequencing millions of blood and DNA samples.
- the HyX Platform includes DNA arrays of samples and probes, software-driven modules, industrial robots for screening DNA probes against DNA samples, and bioinformatic software to analyze the genetic information.
- HyX believes it can carry out a variety of techniques, such as gene identification, gene expression level determination, gene interaction studies (for polygenic diseases), and genetic mapping.
- Affymetrix, Inc. (Santa Clara, Calif.) has a GeneChip system consisting of disposable DNA probe arrays containing gene sequences on a chip, instruments to process the probe arrays, and software to analyze and manage the genetic information in the probe.
- the GeneChip system thus allows pharmaceutical and biotechnology companies to collect gene sequences and apply them to drug development.
- the pharmaceutical industry has a number of genomics companies who first identify the genes which are likely to cause disease. After the genes are identified, they are sequenced and the gene sequences are used in drug development. Likewise, proteins implicated in disease can be identified and sequenced. The sequences can be used to discover the gene sequences, which are then used in drug development.
- Myriad Genetics, Inc. targets families with a history of genetic disease and collects their genetic material in order to identify hereditary disease-causing genes. Myriad is able to identify these genes by using positional cloning and protein interaction studies in combination with targeted discovery gene sequencing. Using these techniques, Myriad has been able to locate and identify eight disease-related gene sequences, including BRCA1 and BRCA2. These gene sequences are used by Myriad's pharmaceutical partners to develop new therapeutics.
- Sequana Another genomics company which uses disease inheritance patterns together with gene sequencing is Sequana (La Jolla, Calif.). Sequana uses DNA collection of individuals with inherited diseases, genotyping and linkage analysis, physical mapping, and gene sequencing to find disease gene sequences. Sequana also has a proprietary bioinformatics system which includes data mining tools to automatically sort and organize much of its data. Like Myriad, Sequana has a number of alliances with drug development companies which license Sequana's gene sequences.
- Millennium Pharmaceuticals, Inc. employs a broader range of technologies than Myriad and Sequana.
- Millennium uses a number of other non-genetic techniques. cDNA libraries are prepared from mouse tissues and expressed using rapid expression of differential gene expression (RARE) technology. Different patterns of cDNA gene expression allow researchers to identify possible disease targets.
- RARE differential gene expression
- Millennium also uses functional cloning techniques in order to identify the gene sequences of interesting proteins. Once a potentially useful gene sequence has been identified, biological assays and bioinformatics are used as additional analyses.
- Genome Therapeutics Corporation uses a combination of positional cloning techniques and targeted discovery gene sequencing, as well as random discovery gene sequencing to isolate and identify disease gene sequences.
- Genome Therapeutics also has pathogen programs, which sequence pathogen genomes. As many non-genetic human diseases result from infection by pathogens, Genome Therapeutics hopes to eliminate pathogens by developing drugs and vaccines using the pathogens' genomes.
- Gene Logic, Inc. (Columbia, Md.) has an accelerated drug discovery system which emphasizes its restriction enzyme analysis of differentially expressed sequences (READS) technology.
- READS is similar in nature to comparative gene expression technology. In READS, normal and diseased tissues are compared in order to identify gene expression differences between the two. Genes which appear to be important in the diseased tissue are then analyzed. Restriction enzymes, which cut gene sequences at specific sites, are used to produce gene fragments. The gene fragments from the normal and diseased tissues will differ and can be compared.
- Gene Logic also has a Flow-thru Chip and genomic databases, which it licenses to drug development companies.
- Progenitor (Columbus, Ohio) focuses on developmental biology. Growing cells and tissues are analyzed for their level of expression of certain genes. Study of growing cells and tissues may help discover treatments for diseases characterized by abnormal cell growth, such as cancer and osteoporosis. Progenitor also uses bioinformatics, gene mapping, and gene sequencing to isolate, identify, and sequence relevant gene sequences.
- OncorMed, Inc. (Gaithersburg, Md.) has focused on the development of medical services using genetic information. Oncormed offers a number of tests for hereditary diseases such as breast and colon cancers and malignant melanoma.
- the medical services include measurements of replication error rates in tumors, molecular profiling of tumor suppresser genes, and gene sequencing.
- OncorMed has a genomics repository containing known cancer gene sequences.
- U.S. Pat. No. 5,642,936 issued to Evans and assigned to OncorMed describes a method for identifying human hereditary disease patterns. According to the method data is collected on individuals hiving a history of disease within their families. Factors related to each disease are given weights, and the weights for each individual are summed. If the sum is above a certain predetermined threshold value, the individual is deemed to have a hereditary risk for the disease. Records from a number of individuals having a hereditary risk for a disease are collected to form a database.
- hereditary disease Gene sequencing and positional cloning represent the two approaches generally taken. However, very little emphasis is put on the environmental aspect of hereditary disease.
- An individual's environment is defined as his or her physical surroundings, geographical location, diet, lifestyle, etc. For many diseases which are genetic in origin, such as most cancers, an individual's environment plays a large role in determining whether or not the individual eventually develops the disease. Some individuals who have disease gene sequences develop diseases, while others who carry the exact same disease gene sequences do not.
- One purpose of collecting environmental data about individuals whose gene sequences are studied is to effectively rule out any non-genetic causes of disease. Another purpose is to discover if any individuals who are carrying disease gene sequences but who do not develop the disease have other compensatory gene sequences or factors which enable them to live disease-free.
- the second group of genomics companies do take into account a small amount of environmental data when they select individuals whose DNA they use for positional cloning analyses.
- the environmental data is usually in the form of a questionnaire or survey.
- the data is typically limited in scope to lifestyle questions, and is used only to help narrow the search for the specific disease gene in question.
- genomics companies are reluctant to share their data on individuals with others, even those genomics companies which are studying the same gene sequences.
- each genomics company must gather its own data on individuals having a certain disease.
- Sequana sent its own researcher to the island of Tristan de Cunha to study hereditary asthma, while Myriad is located in Salt Lake City to take advantage of the detailed family trees of the Mormons.
- gathering environmental data on individuals is often an expensive, time-consuming, but necessary step. Genomics companies could potentially spend more of their time and money on actual disease gene isolation if they were able to obtain necessary environmental data from &other source.
- genomics companies do gather environmental data on the individuals whose gene sequences are studied, the environmental data represents only a small time frame of an individual's life. Few genomics companies continually collect data over a long period of time, and as a result, are not able to definitively rule out certain environmental factors which may affect disease progression. In addition, such data collections are unlikely to provide leads for factors which may prohibit the formation of disease.
- the method includes the step of selecting individuals having d risk factor for a certain disease.
- Each of the individuals is provided with a remotely programmable apparatus having a user interface for communicating queries to the individuals and for receiving responses.
- Each apparatus also includes a communication device, such as a modem, for communicating with a server through a communication network.
- Queries relating to the individuals' environment are entered into the server and transmitted from the server to each individual's remote apparatus. After the individuals have responded to the queries, the responses are sent back to the server and organized into a database. Data mining software is then used to distinguish the individuals into groups based on their environmental profiles. After a period of time, each group is then further divided into categories based on their disease progression. The genomes of all the individuals are then sequenced. Data mining techniques are used to find gene differences between the categories.
- the individuals are first separated into groups according to their disease progressions. Data mining techniques are then used to further distinguish each group into categories based on the individuals' environmental profiles. The genomes of all the individuals are then sequenced, and data mining techniques are used to find gene differences between the categories.
- a third embodiment of the invention provides a method for identifying disease-influencing substances.
- the method includes the step of selecting individuals having a risk factor for a certain disease.
- Each of the individuals is provided with a remotely programmable apparatus having a user interface for communicating queries to the individuals and for receiving responses.
- Each apparatus also includes a communication device, such as a modem, for communicating with a server through a communication network.
- Queries relating to the individuals' environment are entered into the server and transmitted from the server to each individual's remote apparatus. After the individuals have responded to the queries, the responses are sent back to the server and organized into a database. The genomes of all the individuals are then sequences. The individuals are placed into groups based on their gene sequences. Each group is then separated into categories based on the individuals' disease progression. Data mining techniques are then used to find a disease-influencing substance between the categories of individuals by using the individuals environmental profiles.
- the disease influencing gene or substance isolated using these methods is preferably, used to develop drug candidates or drug targets. Additionally, the isolation of the disease-influencing gene is preferably used to identify a corresponding disease-influencing protein, which can also be used to develop drug candidates or drug targets.
- the present invention also provides a database and data processing system for storing and analyzing environmental information about individuals.
- the database and data processing system comprise a server for storing queries and the individuals' responses to the queries.
- the system also includes at least one remotely programmable apparatuses having a user interface for communicating queries to the individuals and for receiving the responses.
- Each apparatus also includes a communication device, such as a modem, for communicating with the server through a communication network.
- the system also includes genotyping means in communication with the server for determining the individuals' gene sequences and a data mining software program accessible to the server for analyzing the individuals gene sequences and environmental profiles.
- the data mining program includes: means for analyzing the responses in order to group the individuals having a similar behavioral and environmental profile, a similar disease progression, and a similar genotype; means for analyzing the responses in order to group the individuals having a similar disease progression; means for analyzing the responses in order to group the individuals having a similar genotype; and means for identifying a disease-influencing gene or substance.
- the database can be used with other genomics or bioinformatics databases and systems if the information is to be manipulated in different ways.
- FIG. 1 is a block diagram of a networked system according to a preferred embodiment of the invention.
- FIG. 2 is a block diagram illustrating the interaction of the components of the system of FIG. 1 .
- FIG. 3 is a perspective view of a remotely programmable apparatus of the system of FIG. 1 .
- FIG. 4 is a block diagram illustrating the components of the apparatus of FIG. 3 .
- FIG. 5 is a script entry screen according to the preferred embodiment of the invention.
- FIG. 6A is a listing of a sample script program according to the preferred embodiment of the invention.
- FIG. 6B is a continuation of the listing of FIG. 6A .
- FIG. 7 is a script assignment screen according to the preferred embodiment of the invention.
- FIG. 8 is a sample query appearing on a display of the apparatus of FIG. 3 .
- FIG. 9 is a sample prompt appearing on the display of the apparatus of FIG. 3 .
- FIG. 10 is a sample report displayed on a workstation of the system of FIG. 1 .
- FIG. 11A is a flow chart illustrating the steps included in a monitoring application executed by the server of FIG. 1 according to the preferred embodiment of the invention.
- FIG. 11A is a continuation of the flow chart of FIG. 11B .
- FIG. 12A is a flow chart illustrating the steps included in the script program of FIGS. 6A-6B .
- FIG. 12B is a continuation of the flow chart of FIG. 12A .
- FIG. 13 is a sample data table of the present invention.
- FIG. 14 is a sample completed data table of the present invention.
- FIG. 15 is a flow chart illustrating a first method for identifying a gene according to the present invention.
- FIG. 16 is a block diagram illustrating the method of FIG. 15 .
- FIG. 17 is a flow chart illustrating a second method for identifying a gene according to the present invention.
- FIG. 18 is a block diagram illustrating the method of FIG. 17 .
- FIG. 19 is a flow chart illustrating a third method according to the present invention.
- FIG. 20 is a block diagram illustrating the method of FIG. 19 .
- the invention presents a system and method for creating a database containing environmental information about an individual to be used in conjunction with the individual's gene sequences to find new drug targets and drug candidates.
- remote monitors are used to collect the environmental information. It is to be understood that environmental information includes all non-genetic information about an individual, such as disease progression, diet, lifestyle, and geographical location.
- a networked system includes a server 50 and a workstation 52 connected to server 50 through a communication network 58 .
- Server 50 is also connected to a patient profile database 54 which stores environmental information about the individuals.
- Server 50 is further connected to a genotyping system 56 which is capable of sequencing individuals' genomes.
- Patient profile database 54 and genotyping system 56 are connected to server 50 through communication network 58 .
- Server 50 and patient profile database 54 are preferably world wide web servers. Server 50 and database 54 may comprise single stand-alone computers or multiple computers distributed throughout a network. Workstation 52 is preferably a personal computer, remote terminal, or web TV unit. Workstation 52 functions as a remote interface for entering in server 50 messages and queries to be communicated to the individuals.
- Genotyping system 56 can be a laboratory capable of sequencing individuals' genomes, a gene sequencing chip such as the Genechip by Affymetrix, or any other suitable genotyping system. Genotyping system 56 should be capable of transmitting information about the individuals' genomes to server 50 .
- Communication network 58 connects workstation 52 , patient profile database 54 , and genotyping system 56 to server 50 .
- Communication network 58 can be any suitable communication network, such as a telephone cable, the Internet, or cellular or wireless communication. Such communication networks are well known in the art.
- the system also includes remotely programmable apparatuses 60 for monitoring individuals.
- each remote apparatus 60 is used to monitor a respective one of the individuals.
- a multi-user apparatus may be used to monitor a plurality of individuals.
- Each remote apparatus is designed to interact with an individual in accordance with script programs received from server 50 .
- Each remote apparatus is in communication with server 50 though communication network 58 , which is preferably the Internet.
- each remote apparatus may be placed in communication with the server via telephone cable, cellular communication, wireless communication, etc.
- FIG. 1 For clarity of illustration, only two remote apparatuses are shown in FIG. 1 . It is to be understood that the system may include any number of remote apparatuses for monitoring any number of individuals.
- each individual to be monitored is also provided with a monitoring device 64 .
- Monitoring device 64 is designed to produce measurements of a physiological condition of the individual, record the measurements, and transmit the measurements to the individual's remote apparatus 60 through a standard connection cable 62 .
- suitable monitoring devices include blood glucose meters, respiratory flow meters, blood pressure cuffs, electronic weight scales, and pulse rate monitors. Such monitoring devices are well known in the art.
- the specific type of monitoring device provided to each individual is dependent upon the individual's disease. For example, diabetes patients are provided with blood glucose meters for measuring blood glucose concentrations, asthma patients are provided with respiratory flow meters for measuring peak flow rates, obesity patients are provided with weight scales, etc.
- FIG. 2 shows server 50 , workstation 52 , and remote apparatus 60 in greater detail.
- Server 50 includes a database 66 for storing script programs 68 .
- the script programs 68 are executed by each remote apparatus 60 to communicate queries and messages to an individual, receive responses 70 to the queries, collect monitoring device measurements 72 , and transmit responses 70 and measurements 72 to server 50 .
- Database 66 is designed to store the responses 70 and measurements 72 .
- Database 66 further includes a look-up table 74 .
- Table 74 contains a list of the individuals to be monitored, and for each individual, a unique-individual identification code and a respective pointer to script program 68 assigned to the individual.
- Each remote apparatus 60 is designed to execute the assigned script program which it receives from server 50 .
- FIGS. 3-4 show the structure of remote apparatus 60 according to the preferred embodiment.
- remote apparatus 60 includes a housing 90 .
- Housing 90 is preferably sufficiently compact to enable the remote apparatus to be handheld and carried by an individual.
- Remote apparatus 60 also includes a user interface for communicating queries to the individual and for receiving responses to the queries.
- the user interface includes a display 92 and four user input buttons 98 A, 98 B, 98 C, and 98 D.
- Display 92 displays queries and prompts to the individual, and is preferably a liquid crystal display (LCD).
- the user input buttons 98 A, 98 B, 98 C, and 98 D are for entering responses to the queries and prompts.
- the user input buttons are preferably momentary contact push buttons.
- the user interface of the preferred embodiment includes a display and input buttons, it will be apparent to one skilled in the art of electronic devices that any suitable user interface may be used in remote apparatus 60 .
- the user input buttons may be replaced by switches, keys, a touch sensitive display screen, or any other data input device.
- the display and input buttons may be replaced by a speech synthesis/speech recognition interface.
- Three monitoring device jacks 96 A, 96 B, and 96 C are located on a surface of housing 90 .
- Device jacks 96 A, 96 B, and 96 C are for connecting remote apparatus 60 to a number of monitoring devices, such as blood glucose meters, respiratory flow meters, or blood pressure cuffs, through standard connection cables (not shown).
- the apparatus 60 also includes a modem jack 94 for connecting remote apparatus 60 to a telephone jack through a standard connection cord (not shown).
- Remote apparatus 60 further includes a visual indicator, such as a light emitting diode (LED) 100 . LED 100 is for visually notifying the individual that he or she has unanswered queries stored in remote apparatus 60 .
- LED 100 is for visually notifying the individual that he or she has unanswered queries stored in remote apparatus 60 .
- FIG. 4 is a schematic block diagram illustrating the components of remote apparatus 60 in greater detail.
- Remote apparatus 60 includes a microprocessor 102 and a memory 108 connected to microprocessor 102 .
- Memory 108 is preferably a non-volatile memory, such as a serial EEPROM.
- Memory 108 stores script programs received from the server, measurements received from monitoring device 64 , responses to queries, and the individual's unique identification code.
- Microprocessor 102 also includes built-in read-only memory (ROM) which, stores firmware for controlling the operation of remote apparatus 60 .
- the firmware includes a script interpreter used by microprocessor 102 to execute the script programs.
- the script interpreter interprets script commands which are executed by microprocessor 102 . Specific techniques for interpreting and executing script programs in this manner are well known in the art.
- Microprocessor 102 is preferably connected to memory 108 using a standard two-wire I 2 C interface. Microprocessor 102 is also connected to user input buttons 98 A, 98 B, 98 C, and 98 D. LED 100 , a clock 112 , and a display driver 110 . Clock 112 indicates the current date and time to microprocessor 102 . For clarity of illustration, clock 112 is shown as a separate component, but is preferably built into microprocessor 102 .
- Display driver 110 operates under the control of microprocessor 102 to display information on display 92 .
- Microprocessor 102 is preferably a PIC 16C65 processor which includes a universal asynchronous receiver transmitter (UART) 104 . UART 104 is for communicating with a modem 114 and a device interface 118 . A CMOS switch 116 under the control of microprocessor 102 alternately connects modem 114 and interface 118 to UART 116 .
- UART universal asynchronous receiver transmitter
- Modem 114 is connected to a telephone jack 119 through modem jack 94 .
- Modem 114 is for exchanging data with the server through the communication network.
- the data includes script programs which are received from the server as well as responses to queries, device measurements, script identification codes, and the individual's unique identification code which modem 114 transmits to server 50 .
- Modem 114 is preferably a complete 28.8 K modem commercially available from Cermetek, although any suitable modem may be used.
- Device interface 118 is connected to device jacks 96 A, 96 B, and 96 C.
- Device interface 118 is for interfacing with a number of monitoring devices, such as blood glucose meters, respiratory flow meters, blood pressure cuffs, weight scales, or pulse rate monitors, through device jacks 96 A, 96 B, and 96 C.
- Device interface 118 operates under the control of microprocessor 102 to collect measurements 72 from monitoring devices 64 and to output measurements 72 to microprocessor 102 for storage in memory 108 .
- interface 118 is a standard RS232 interface. For simplicity of illustration, only one device interface 118 is shown in FIG. 4 . However, in alternative embodiments, remote apparatus 60 may include multiple device interfaces to accommodate monitoring devices which have different connection standards.
- server 50 includes a monitoring application 76 .
- Monitoring application 76 is a controlling software application executed by server 50 to perform the various functions described below.
- Monitoring application 76 includes a script generator 78 , a script assignor 80 , and a report generator 82 .
- Script generator 78 is designed to generate script programs 68 from script information entered through workstation 52 .
- the script information is entered through a script entry screen 84 .
- script entry screen 84 is implemented as a web page on the server 50 .
- Workstation 52 includes a web browser for accessing the web page to enter the script information.
- FIG. 5 illustrates script entry screen 84 as it appears on workstation 52 .
- Script entry screen 84 includes a script name field 120 for specifying the name of script program to be generated.
- Screen 84 also includes entry fields 122 for entering a set of queries to be answered by an individual. Each entry field 122 has corresponding response choice fields 124 for entering response choices for the query.
- Screen 84 further includes check boxes 126 for selecting a desired monitoring device type from which to collect measurements, such as a blood glucose meter, respiratory flow meter, or blood pressure cuff.
- Screen 84 additionally includes a connection time field 128 for specifying a prescribed connection time at which each remote apparatus executing the script program is to establish a subsequent communication link to the server.
- the connection time is preferably selected to be the time at which communication rates are the lowest, such as 3:00 AM.
- Screen 84 also includes a CREATE SCRIPT button 130 for instructing the script generator to generate a script program from the information entered in screen 84 .
- Screen 84 further includes a CANCEL button 132 for canceling the information entered.
- each script program created by the script generator 82 conforms to the standard file format used on UNIX systems.
- each command is listed in the upper case and followed by a colon. Every line in the script program is terminated by a linefeed character ⁇ LF ⁇ , and only one command is placed on each line.
- the last character in the script program is a UNIX end of file character ⁇ EOF ⁇ .
- TABLE 1 shows an exemplary listing of script commands used in the preferred embodiment of the invention.
- Command Description CLS: ⁇ LF ⁇ Clear the display ZAP: ⁇ LF ⁇ Erase from memory the last set of query responses recorded.
- DISPLAY (chars) ⁇ LF ⁇ Display the text following the DISPLAY command
- INPUT mmmm ⁇ LF ⁇ Record a button press.
- the m's represent a button mask pattern for each of the four input buttons.
- Each m contains an “X” for disallowed buttons or an “0” for allowed buttons., For example, INPUT: OXOX ⁇ LF) allows the user to press either button #1 or #3.
- WAIT ⁇ LF ⁇ Wait for any one button to be pressed, then continue executing the script program.
- COLLECT device ⁇ LF1 ⁇ Collect measurements from the monitoring device specified in the COLLECT command.
- NUMBER aaaa ⁇ LF ⁇ Assign a script identification code to the script program.
- the script identification code ‘from the most recently executed NUMBER statement is subsequently transmitted to the server along with the query responses and device measurements.
- the script identification code identifies to the server which script program was most recently executed by the-remote apparatus.
- DELAY t ⁇ LF ⁇ Wait until time t specified in the DELAY command, usually the prescribed connection time.
- Script generator 78 preferably stores a script program template which it uses to create each script program. To generate a script program, script generator 78 inserts into the template the script information entered in script entry screen 84 .
- FIGS. 6A-6B illustrate a sample script program created by the script generator from the script information shown in FIG. 5 .
- the script program includes display commands to display the queries and response choices entered in fields 122 and 124 ; respectively.
- the script program also includes input commands to receive responses to the queries.
- the script program further includes a collect command to collect device measurements from the monitoring device specified in check boxes 126 .
- the script program also includes commands to establish a subsequent communication link to the server at the connection time specified in field 128 .
- the steps included in the sample script program are also shown in the flow chart of FIGS. 12A-12B and will be discussed in the operation section below.
- script assignor 80 is for assigning the script programs 68 to the individuals.
- the script programs are assigned in accordance with script assignment information entered through workstation 52 .
- the script assignment information is entered through a script assignment screen 86 , which is preferably implemented as a web page on server 50 .
- FIG. 7 shows a sample script assignment screen 86 as it appears on the workstation.
- Screen 86 includes check boxes 134 for selecting the script program to be assigned and check boxes 136 for selecting the individuals to whom the script program is to be assigned.
- Screen 86 also includes an ASSIGN SCRIPT button 140 for entering the assignments. When button 140 is pressed, the script assignor creates and stores for each individual selected in check boxes 136 a respective pointer to the script program selected in check boxes 134 . Each pointer is stored in the look-up table 74 of database 66 .
- Screen 86 further includes an ADD SCRIPT button 138 for accessing the script entry screen and a DELETE SCRIPT button 142 for a deleting script program.
- report generator 82 is designed to generate a report 88 from the responses 70 and device measurements 72 received in server 50 .
- Report 88 is displayed on workstation 52 .
- FIG. 10 shows a sample patient report 88 produced by report generator 82 for a selected individual.
- Report 88 includes a graph 146 of the device measurements received from the individual, as well as a listing of the query responses received from the individual. Specific techniques for writing a report generator program to display data in this manner are well known in the software art.
- FIG. 11A is a flow chart illustrating steps included in the monitoring application executed by server 50 .
- FIG. 11B is a continuation of the flow chart of FIG. 11A .
- step 202 the server determines if new script information has been entered through script entry screen 84 . If new script information has not been entered, the server proceeds to step 206 . If new script information has been entered, the server proceeds to step 204 .
- the script information includes a set of queries, and for each of the queries, corresponding responses choices.
- the script information also includes a selected monitoring device type from which to collect measurements.
- the script information further includes a prescribed connection time for each remote apparatus to establish a subsequent communication link to the server.
- the script information is generally entered in the server by a healthcare provider, such as the individuals' physician or case manager. Of course, any person desiring to communicate with the individual may also be granted access to the server to create and assign script programs. Further, it is to be understood that the system may include any number of workstations for entering script generation and script assignment information into the server.
- step 204 script generator 78 generates a script program from the information entered in screen 84 .
- the script program is stored in database 66 .
- Steps 202 and 204 are preferably repeated to generate multiple script programs, e.g. a script program for diabetes patients, a script program for asthma patients, etc.
- Each script program corresponds to a respective one of the sets of queries entered through script entry screen 84 .
- the server proceeds to step 206 .
- step 206 the server determines if new script assignment information has been entered through script assignment screen 86 . If new script assignment information has not been entered, the server proceeds to step 210 . If new script assignment information has been entered, the server proceeds to step 208 .
- script programs are assigned to each individual by selecting a script program through check boxes 134 , selecting the individuals to whom selected the script program is to be assigned through check boxes 136 , and pressing the ASSIGN SCRIPT button 140 .
- button 140 is pressed, script assignor 86 creates for each individual selected in check boxes 136 a respective pointer to the script program selected in check boxes 134 .
- each pointer is stored in look-up table 74 of database 66 . Following step 208 , the server proceeds to step 210 .
- step 210 the server determines if any of the remote apparatuses are remotely connected to the server.
- Each individual to be monitored is preferably provided with his or her own remote apparatus which has the individual's unique identification code stored therein. Each individual is thus uniquely associated with a respective one of the remote apparatuses. If none of remote apparatuses are connected, the server proceeds to step 220 .
- the server receives from the apparatus the individual's unique identification code in step 212 .
- the server receives from the apparatus the query responses, device measurements, and script identification code recorded during execution of a previously assigned script program.
- the script identification code identifies to the server which script program was executed by the remote apparatus to record the query responses and device measurements.
- the responses, device measurements, and script identification code are stored in database 66 .
- step 216 the server uses the individual's unique identification code to retrieve from look-up table 74 the pointer to the script program assigned to the individual. The server then retrieves the assigned script program from the database 66 . In step 218 , the server transmits the assigned script program to the individual's remote apparatus through the communication network 58 . Following step 218 , the server proceeds to step 220 .
- step 220 the server determines if a report request has been received from workstation 52 . If no report request has been received, the server returns to step 202 . If a report request has been received for a selected individual, the server retrieves from database 66 the query responses and measurements last received from the individual, step 222 . In step 224 , the server generates and displays the report 88 on workstation 52 .
- the report includes the query responses and device measurements last received from the individual.
- the server returns to step 202 .
- FIGS. 12A-12B illustrate the steps included in a sample script program executed by the remote apparatus.
- the remote apparatus is initially programmed with the individual's unique identification code and the script interpreter used by microprocessor 102 to execute script programs.
- the initial programming may be achieved during manufacture or during an initial connection to the server.
- the remote apparatus receives from the server the script program assigned to the individual associated with the apparatus.
- the script program is received by modem 114 through a first communication link to the server and stored in memory 108 .
- microprocessor 102 assigns a script identification code to the script program and stores the script identification code in memory 108 .
- the script identification code is subsequently transmitted to the server along with query responses and device measurements to identify to the server which script program was most recently executed by the remote apparatus.
- microprocessor 102 lights LED 100 to notify the individual that he or she has unanswered queries stored in the remote apparatus. LED 100 preferably remains lit until the queries are answered by the individual.
- microprocessor 102 erases from memory 108 the last set of query responses recorded.
- microprocessor 102 prompts the individual by displaying on display 92 “ANSWER QUERIES NOW? PRESS ANY BUTTON TO START”.
- microprocessor 102 waits until a reply to the prompt is received from the individual. When a reply is received, microprocessor 102 proceeds to step 312 .
- microprocessor 102 executes successive display and input commands to display the queries and response choices on display 92 and to receive responses to the queries.
- FIG. 8 illustrate a sample query and its corresponding response choices as they appear on display 92 .
- the response choices are preferably positioned on display 92 such that each response choice is located proximate a respective one of the user input buttons 98 A, 98 B, 98 C, and 98 D.
- each response choice is displayed immediately above a respective user input button. The individual presses the button corresponding to his or her response, and microprocessor 102 stores the response in memory 108 .
- microprocessor 102 executes commands to collect device measurements from a selected monitoring device specified in the script program.
- microprocessor 102 prompts the individual to connect the selected device to one of the device jacks 96 A, 96 B, or 96 C.
- a sample prompt is shown in FIG. 9 .
- microprocessor 102 waits until a reply to the prompt is received from the individual. When a reply is received, microprocessor 102 proceeds to step. 318 .
- Microprocessor 102 also connects UART 104 to device interface 118 through CMOS switch 116 .
- microprocessor 102 collects device measurements from the selected device through device interface 118 . The device measurements are stored in memory 108 .
- microprocessor 102 prompts the individual to connect remote apparatus 60 to telephone jack 119 so that the apparatus may connect to the server at the prescribed connection time.
- microprocessor 102 waits until a reply to the prompt is received from the individual. When a reply is received, microprocessor 102 turns off LED 100 in step 324 .
- microprocessor 102 waits until it is time to connect to the server.
- Microprocessor 102 compares the connection time specified in the script program to the current time output by clock 112 . When it is time to connect, microprocessor 102 connects UART 104 to modem 114 through CMOS switch 116 .
- microprocessor 102 establishes a subsequent communication link between remote apparatus 60 and server 50 through modem 114 and communication network 58 . If the connection fails for any reason, microprocessor 102 repeats step 328 to get a successful connection.
- microprocessor 102 transmits the query responses, device measurements, script identification code, and the individual's unique identification code stored in memory 108 to the server.
- microprocessor 102 receives through modem 114 a newly assigned script program from the server. The new script program is stored in memory 108 for subsequent execution by microprocessor 102 . Following step 332 , the script program ends.
- the data mining program includes a data table 150 , as shown in FIG. 13 .
- Data table 150 is stored on the server and has an individual identification number field 151 , name fields 152 , value fields 154 corresponding to the name fields, and explanation fields 156 corresponding to the name fields and value fields.
- the data type is entered into name fields 152 , the possible numerical values corresponding to the data type are entered into value fields 154 , and brief explanations of the data types and corresponding values are entered into explanation fields 156 .
- the individuals' device measurements and responses to the queries are entered into data table 150 in the form of numerical values in value fields 154 .
- the individual's identification number is entered into individual identification number field 151 .
- An example of data table 150 in which the individuals' information has been entered is shown in FIG. 14 . Once data table 150 contains all the necessary information, the data mining program then compares the information.
- FIG. 15 is a flowchart illustrating a first method of the present invention carried out by the server using the data mining techniques described above.
- step 400 individuals having a risk factor for a disease are selected.
- step 402 these individuals are queried about their behavior and environment using the script programs and remote apparatuses previously described.
- the responses to the queries and any device measurements are received and stored by the server. Collection of the responses and device measurements can occur over any period of time, thus allowing for more accurate data.
- a database comprising the individuals' behavioral and environmental profiles is created in step 404 .
- data mining techniques are used to group individuals having similar behavioral and environmental profiles.
- the server determines if it is necessary to further group the individuals in order to produce smaller groups. Steps 406 and 408 can be repeated as often as necessary.
- each group of individuals is categorized using data mining techniques.
- the individuals are categorized according to their disease progressions. For example, a group of individuals can be categorized into those that have a severe disease phenotype, those that have a moderate disease phenotype, and those that have a mild disease phenotype.
- the server determines if it is necessary to further categorize the individuals. Steps 410 and 412 can be repeated as often as necessary.
- step 414 the genomes of all the individuals are sequenced by genotyping system 56 .
- the genotypes of all the individuals are transmitted to server 50 .
- step 416 data mining techniques are used to compare the genotypes of the individuals between the categories. For example, if those individuals who have a severe disease phenotype and are overweight have a certain gene sequence, while those individuals who have a mild disease phenotype and are overweight do not, it is likely the gene sequence is responsible for the severe disease phenotype. If a gene sequence is found, it is further identified in step 418 . Methods of isolating and identifying gene sequences are well known in the field.
- FIG. 16 is a block diagram illustrating an example of the first method of the present invention as described in FIG. 15 .
- First individuals having a risk factor for a certain disease such as non-insulin dependent diabetes mellitus (NIDDM)
- NIDDM non-insulin dependent diabetes mellitus
- Behavioral and environmental information from each individual is collected using the script programs and remote apparatuses.
- the individuals are then grouped into overweight individuals 424 and non-overweight individuals 426 .
- the individuals are then categorized into overweight individuals having severe NIDDM 428 , overweight individuals having mild NIDDM 430 , non-overweight individuals having mild NIDDM 432 , and non-overweight individuals having severe NIDDM 434 .
- the individuals' genotype information is then taken, as indicated at block 436 , to determine the individuals' gene sequences. For example, overweight individuals with severe NIDDM have gene sequence A, overweight individuals with mild NIDDM have gene sequence B, non-overweight individuals with mild NIDDM have gene sequence B, and non-overweight individuals with severe NIDDM have gene sequence A. Data mining techniques are then used to analyze the information and come to a conclusion. In this example, data mining would conclude that the severe NIDDM phenotype is likely related to gene sequence A, not the individual's weight.
- FIG. 17 shows a flowchart illustrating a second method of the present invention carried out by the server using the data mining techniques described above.
- step 500 individuals having a risk factor for a disease are selected.
- step 502 these individuals are queried about their behavior and environment using the script programs and remote apparatuses previously described. The responses to the queries and any device measurements are received and stored by the server.
- a database comprising the individuals' behavioral and environmental profiles is created in step 504 .
- data mining techniques are used to group together individuals having similar disease progressions. For example, a group of individuals can be grouped into those that have a severe disease phenotype, those that have a moderate, disease phenotype, and those that have a mild disease phenotype.
- the server determines if it is necessary to further group the individuals in order to produce smaller groups. Steps 506 and 508 can be repeated as often as necessary.
- each group of individuals created in steps 506 and 508 is categorized using data mining techniques according to the behavioral and environmental profiles of the individuals.
- the server determines if it is necessary to further group the individuals in order to produce smaller groups. Steps 510 and 512 can be repeated as often as necessary.
- step 514 the genomes of all the individuals are sequenced by genotyping system 56 .
- the genotypes of all the individuals are transmitted to the server.
- step 516 data mining techniques are used to compare the genotypes of the individuals between the categories. For example, if those individuals who have a severe disease phenotype and are overweight have a certain gene sequence, while those individuals who have a mild disease and are also overweight phenotype do not, it is likely the gene sequence, not weight; is responsible for the severe disease phenotype. If a gene sequence is found, it is further identified in step 518 . Specific techniques of isolating and identifying gene sequences are well known in the field.
- FIG. 18 is a block diagram illustrating an example of the second method of the present invention as described in FIG. 17 .
- First individuals having a risk factor for a certain disease, such as NIDDM are chosen, as indicated at block 522 .
- Behavioral and environmental information from each individual is collected using the remote apparatuses and script programs.
- the individuals are then grouped into those exhibiting severe NIDDM 524 and those exhibiting mild NIDDM 526 .
- the individuals are then categorized into overweight individuals having severe NIDDM 528 , non-overweight individuals having severe NIDDM 530 , non-overweight individuals having mild NIDDM 532 , and overweight individuals having mild NIDDM 534 .
- the individuals' genotype information is then taken, as indicated at block 536 , to determine the individuals' gene sequences. For example, individuals with severe NIDDM who are overweight have gene sequence A, individuals with severe NIDDM who are non-overweight have gene sequence A, individuals with mild NIDDM who are non-overweight have gene sequence B, and individuals with severe NIDDM who are overweight have gene sequence B.
- Data mining techniques are then used to analyze the information and come to a conclusion. In this example, data mining would conclude that the severe NIDDM phenotype is likely related to gene sequence A, not the individual's weight.
- FIG. 19 shows a flowchart illustrating a preferred method carried out by server 50 to identify a disease-identifying substance.
- step 600 individuals having a risk factor for a disease are selected.
- step 602 these individuals are queried about their behavior and environment using the script programs and remote apparatuses previously described. The responses to the queries and any device measurements are received and stored by the server.
- a database comprising the individuals' behavioral and environmental profiles is created in step 604 .
- the genomes of all the individuals are sequenced, and the genotypes of all the individuals are transmitted to the server.
- individuals having the same or close genotypes are grouped together.
- data mining techniques are used to categorize together individuals, having similar disease progressions.
- the server determines if it is necessary to further categorize the individuals in order to produce smaller groups. Steps 610 and 612 can be repeated as often as necessary.
- step 614 data mining techniques are used to find a disease influencing substance between the categories of individuals by using the individuals behavioral and environmental profiles. For example, if those individuals who have a severe disease phenotype are overweight, while those individuals who have a mild disease phenotype are not, it is likely weight is responsible for the severe disease phenotype. If such a disease-influencing substance is found, it is identified in step 618 . If no disease-influencing substance is found, the process is preferably repeated.
- FIG. 20 is a block diagram illustrating an example of the method described in FIG. 19 .
- individuals having a risk factor for a certain disease such as NIDDM are chosen, as indicated at block 620 .
- Behavioral and environmental information from each individual is collected using the remote apparatuses and script programs.
- the individuals' genotype information is then taken, as indicated at block 622 , to determine the individuals' gene sequences.
- the individuals are then grouped according to their gene sequences. For example, one group may have gene sequence A, as indicated at block 624 , while another group may have gene sequence B, as indicated at block 626 .
- the individuals are then categorized into individuals with gene sequence A having severe NIDDM 628 , individuals with gene sequence A having mild NIDDM 630 , individuals with gene sequence B having mild NIDDM 632 , and individuals with gene sequence B having severe NIDDM 634 .
- Data mining techniques are further used to analyze the categories of individuals and their behavioral and environmental profiles. For example, overweight individuals 638 with severe NIDDM have gene sequence A, non-overweight individuals 640 with mild NIDDM have gene sequence A, overweight individuals 642 with mild NIDDM have gene sequence B, and non-overweight individuals 644 with severe NIDDM have gene sequence B. Data mining techniques are then used to analyze the information and come to a conclusion. In this example, data mining would conclude that the severe NIDDM phenotype is likely related to gene sequence A, not the individual's weight.
- the invention is not limited to the specific applications described.
- the system and method of the invention have many other applications.
- pharmaceutical manufacturers may apply the system in clinical trials to analyze new drug data.
Abstract
The present invention describes a system and method of using individuals' behavioral and physiologic information to identify disease-influencing genes.
Description
- This is a divisional application of application Ser. No. 09/496,893, filed Feb. 2, 2000, which is a continuation application of application Ser. No. 09/041,809, filed Mar. 13, 1998, now abandoned, which is a continuation-in-part of application Ser. No. 08/946,341, filed Oct. 7, 1997, now U.S. Pat. No. 5,997,476, which is a continuation-in-part of application Ser. No. 08/847,009, filed Apr. 30, 1997, now U.S. Pat. No. 5,897,493, which claims priority to provisional application Ser. No. 60/041,746 filed on Mar. 28, 1997 and provisional application Ser. No. 60/041,751 filed Mar. 28, 1997.
- This application is also a continuation-in-part of application Ser. No. 09/378,188, filed on Aug. 20, 1999, now abandoned, which is a continuation of application Ser. No. 08/850,840 filed on May 3, 1997 now U.S. Pat. No. 5,985,559, which is a continuation of application Ser. No. 08/847,009 filed Apr. 30, 1997, now U.S. Pat. No. 5,897,493, which claims priority to provisional application Ser. No. 60/041,746, filed on Mar. 28, 1997 and provisional application Ser. No. 60/041,751, filed on Mar. 28, 1997. All applications, except to the extent, if any, such incorporation would constitute new matter, are herein incorporated by reference in their entirety as if fully set forth herein.
- This invention relates generally to the fields of genomics, bioinformatics, and drug development. More specifically, it relates to a database containing phenotypic and environmental data on groups of individuals for use in conjunction with gene sequences to identify disease-influencing genes and substances.
- The physical makeup of an individual is determined by his or her genes. Genes are comprised of DNA, which in turn consists of four nucleotides known as adenine (A), thymine (T), cytosine (C), and guanine (G). A particular series of nucleotides is known as a gene sequence. Each gene sequence codes for a protein. A defective or mutant gene sequence will not produce a working protein. The protein may not perform its purpose, the protein may carry out a different purpose than intended, too much protein may be made, too little protein may be made, or the protein may not be made at all. If the protein is essential to one or more functions of the body, disease will result.
- Mutant gene sequences are either inherited or acquired. An inherited gene sequence is received from an individual's parents, while an acquired gene sequence results from an event in the individual's lifetime which changes the original gene sequence.
- A classic example of an inherited mutant gene sequence is the sickle cell anemia gene. Sickle cell anemia is caused by the substitution of a single nucleotide (A to T) in the gene sequence of an individual. This single substitution results in the substitution of a single amino acid (glutamic acid to valine) in the resulting hemoglobin protein. The mutant hemoglobin protein produces crescent-shaped or sickled red blood cells in affected individuals, causing a decrease in the amount of oxygen that can be transported throughout the body. The lack of oxygen often results in kidney and heart failure, paralysis, and rheumatism, which are common symptoms of anemic individuals.
- An example of an acquired mutant gene sequence is malignant melanoma, or skin cancer. Cancer results when normal cells in an individuals body either lose or gain certain functions, resulting in the unchecked growth of non-normal cells. These non-normal cells often form tumors and spread throughout the body, disrupting normal cell functions. A cancer such as malignant melanoma is caused when the original gene sequence in epidermal cells is changed or mutated by an environmental factor, such as UV radiation. Our cells contain repair mechanisms to fix such problems, but over time the gene sequences in epidermal cells acquire more and more mutations. Mutant proteins are then produced and cellular functions are disrupted. The individual then has skin cancer.
- Although an individual's environment generally precipitates the development of cancer, many individuals have been found to have a predisposition to cancer. These individuals have gene sequences which are more likely to become mutated over a shorter period of time. Examples of such gene sequences are the BRCA1 and BRCA2 genes. Women carrying these gene sequences have a higher probability of developing breast and ovarian cancer than women who carry normal gene sequences. Thus, although the affected women's original gene sequences may not be mutated, they are more likely to become mutated due to their sequence or location on a chromosome.
- Another factor that should be considered when discussing genetic diseases is whether they are monogenic or polygenic in nature. Sickle cell anemia and cystic fibrosis are examples of monogenic diseases, as they are caused by a single gene sequence. Most types of cancer, asthma, and diabetes are examples of polygenic diseases, as they are caused by a variety of genes. Polygenic diseases are also more likely to be influenced by an individual's environment. Not surprisingly, polygenic diseases are more difficult to diagnose and treat. Thus, the use of gene sequences in developing new drugs is dependent the monogenic or polygenic nature of genetic diseases.
- Typically, individuals with diseases caused by inherited or acquired gene sequences have only their symptoms, treated. Diabetes patients receive insulin shots to regulate their blood glucose levels, asthma patients use inhalers to allow normal respiratory functions, and cancer patients undergo chemotherapy and radiation therapy to remove cancerous tumors. Although these treatments are often able to alleviate or eliminate the symptoms, they are unable to remove the genetic bases of the diseases.
- The genetic bases of many diseases were discovered in the 1940's by scientists such as Beadle and Tatum, who discovered that each gene codes for a protein. Researchers then rationalized that study of the relevant gene sequences could lead to effective drug treatments for genetic diseases. The technology was inadequate, however, until the 1970-80's, when Boyer and Cohen cloned DNA; Maxam, Gilbert, and Sanger figured out how to sequence DNA; and Mullis developed the polymerase chain reaction (PCR) technique to quickly amplify DNA sequences. Using genetics to find drug candidates soon became a practical option.
- Before these techniques became available, the pharmaceutical industry's main method of finding new drugs was trial and error. Compounds that were found to mimic the body's natural compounds were tested in vitro, in animal models, and in clinical trials to see if they had a desirable effect in treating disease. This method is still used and has resulted in many well-known drugs, but it is expensive and time-consuming.
- With the advent of improved genetic techniques, however, the pharmaceutical industry has begun concentrating on genetics as the most effective route to new drug discovery. Genomics companies can typically be classified into one of two groups.
- The first group concentrates on gene sequencing in order to find both drug targets and drug candidates, usually in the form of proteins expressed by the gene sequences. Gene sequencing can either be in the form of random, discovery, whereby genes are sequenced without regard to their functions, or in the form of targeted discovery, whereby a certain region of the genome which is tentatively associated with a disease is sequenced. In random discovery gene sequencing, potentially useful gene sequences are identified and assayed to determine if they can be used in drug development. One problem with random discovery gene sequencing is that the majority of the human genome contains introns, or gene sequences which do not code for proteins. One way to circumvent this problem is to sequence complementary DNA (cDNA) instead. cDNA is produced from messenger RNA (mRNA). mRNA, in turn, is transcribed from DNA and processed by certain enzymes which remove the introns. cDNA sequences thus code for un-interrupted proteins.
- Targeted discovery gene sequencing is typically used with positional cloning, comparative gene expression, and functional cloning techniques, which are described in the next group.
- The second group of genomics companies takes a more epidemiological approach by first researching families or groups of individuals having a similar disease, and then isolating the relevant genes. In this method, also known as positional cloning, blood samples are taken from the individuals and analyzed. The blood samples contain DNA, which is studied to identify certain regions of the genome which appear to be associated with the disease. Linking a region of the genome with a disease is known as linkage analysis or genetic linkage mapping. Once a region of the genome has been identified, it is sequenced via targeted discovery gene sequencing.
- The second group of genomics companies also uses comparative gene expression to discover disease gene sequences. In comparative gene expression, mRNA from both healthy and diseased tissue is isolated. The mRNA is then used to produce cDNA, which is sequenced using targeted discovery gene sequencing. The gene sequences from both the healthy and diseased tissue are then compared. In addition, the identification of genes associated with disease can be made by studying the level of expression of genes in both the healthy and diseased tissue.
- Another similar technique is functional cloning. Mutant or non-functional proteins in metabolic pathways are studied and identified. The proteins are sequenced using targeted discovery gene sequencing and these sequences are used to figure out the corresponding DNA gene sequences. Once the disease gene sequences have been identified, they can be used in drug development.
- Genomics companies in the first group include Incyte pharmaceuticals (Palo Alto, Calif.). Incyte uses random discovery gene sequencing to produce its LifeSeq™ and LifeSeq FL™ databases. These databases contain the sequences of hundreds of human genes. These databases are licensed to drug development companies who use the sequences to produce new drugs. Databases covering animals (ZooSeq™), plants (PhytoSeq™), and bacteria and fungi (PathoSeq™) are also available. Incyte has also developed bioinformatics software, which provides sequence analysis and data management for their databases. In addition, Incyte offers cDNA libraries of the gene sequences in their databases, which can be directly used in drug development.
- Human Genome Sciences (Rockville, Md.) also concentrates on random discovery gene sequencing, and has sequenced an estimated 90% of the 100,000 genes in the human body. In addition to collaborating with drug development companies who use their gene sequences, HGS also has its own drug discovery and development division. A number of therapeutic proteins which appear effective in animal models are under study.
- HySeq, Inc. (Sunnyvale, Calif.) has its HyX Platform which is capable of processing and sequencing millions of blood and DNA samples. The HyX Platform includes DNA arrays of samples and probes, software-driven modules, industrial robots for screening DNA probes against DNA samples, and bioinformatic software to analyze the genetic information. Through the use of its HyX Platform, HyX believes it can carry out a variety of techniques, such as gene identification, gene expression level determination, gene interaction studies (for polygenic diseases), and genetic mapping.
- Affymetrix, Inc. (Santa Clara, Calif.) has a GeneChip system consisting of disposable DNA probe arrays containing gene sequences on a chip, instruments to process the probe arrays, and software to analyze and manage the genetic information in the probe. The GeneChip system thus allows pharmaceutical and biotechnology companies to collect gene sequences and apply them to drug development.
- On the other hand, the pharmaceutical industry has a number of genomics companies who first identify the genes which are likely to cause disease. After the genes are identified, they are sequenced and the gene sequences are used in drug development. Likewise, proteins implicated in disease can be identified and sequenced. The sequences can be used to discover the gene sequences, which are then used in drug development.
- Myriad Genetics, Inc. (Salt Lake City, Utah) targets families with a history of genetic disease and collects their genetic material in order to identify hereditary disease-causing genes. Myriad is able to identify these genes by using positional cloning and protein interaction studies in combination with targeted discovery gene sequencing. Using these techniques, Myriad has been able to locate and identify eight disease-related gene sequences, including BRCA1 and BRCA2. These gene sequences are used by Myriad's pharmaceutical partners to develop new therapeutics.
- Another genomics company which uses disease inheritance patterns together with gene sequencing is Sequana (La Jolla, Calif.). Sequana uses DNA collection of individuals with inherited diseases, genotyping and linkage analysis, physical mapping, and gene sequencing to find disease gene sequences. Sequana also has a proprietary bioinformatics system which includes data mining tools to automatically sort and organize much of its data. Like Myriad, Sequana has a number of alliances with drug development companies which license Sequana's gene sequences.
- Millennium Pharmaceuticals, Inc. (Cambridge, Mass.) employs a broader range of technologies than Myriad and Sequana. In addition to positional cloning and targeted discovery gene sequencing, Millennium uses a number of other non-genetic techniques. cDNA libraries are prepared from mouse tissues and expressed using rapid expression of differential gene expression (RARE) technology. Different patterns of cDNA gene expression allow researchers to identify possible disease targets. Millennium also uses functional cloning techniques in order to identify the gene sequences of interesting proteins. Once a potentially useful gene sequence has been identified, biological assays and bioinformatics are used as additional analyses.
- Genome Therapeutics Corporation (Waltham, Mass.) uses a combination of positional cloning techniques and targeted discovery gene sequencing, as well as random discovery gene sequencing to isolate and identify disease gene sequences. In addition, Genome Therapeutics also has pathogen programs, which sequence pathogen genomes. As many non-genetic human diseases result from infection by pathogens, Genome Therapeutics hopes to eliminate pathogens by developing drugs and vaccines using the pathogens' genomes.
- Gene Logic, Inc. (Columbia, Md.) has an accelerated drug discovery system which emphasizes its restriction enzyme analysis of differentially expressed sequences (READS) technology. READS is similar in nature to comparative gene expression technology. In READS, normal and diseased tissues are compared in order to identify gene expression differences between the two. Genes which appear to be important in the diseased tissue are then analyzed. Restriction enzymes, which cut gene sequences at specific sites, are used to produce gene fragments. The gene fragments from the normal and diseased tissues will differ and can be compared. Gene Logic also has a Flow-thru Chip and genomic databases, which it licenses to drug development companies.
- Progenitor (Columbus, Ohio) focuses on developmental biology. Growing cells and tissues are analyzed for their level of expression of certain genes. Study of growing cells and tissues may help discover treatments for diseases characterized by abnormal cell growth, such as cancer and osteoporosis. Progenitor also uses bioinformatics, gene mapping, and gene sequencing to isolate, identify, and sequence relevant gene sequences.
- OncorMed, Inc. (Gaithersburg, Md.) has focused on the development of medical services using genetic information. Oncormed offers a number of tests for hereditary diseases such as breast and colon cancers and malignant melanoma. The medical services include measurements of replication error rates in tumors, molecular profiling of tumor suppresser genes, and gene sequencing. In addition, OncorMed has a genomics repository containing known cancer gene sequences.
- U.S. Pat. No. 5,642,936 issued to Evans and assigned to OncorMed describes a method for identifying human hereditary disease patterns. According to the method data is collected on individuals hiving a history of disease within their families. Factors related to each disease are given weights, and the weights for each individual are summed. If the sum is above a certain predetermined threshold value, the individual is deemed to have a hereditary risk for the disease. Records from a number of individuals having a hereditary risk for a disease are collected to form a database.
- The methods used by the above companies all focus on the genetic aspect of hereditary disease. Gene sequencing and positional cloning represent the two approaches generally taken. However, very little emphasis is put on the environmental aspect of hereditary disease. An individual's environment is defined as his or her physical surroundings, geographical location, diet, lifestyle, etc. For many diseases which are genetic in origin, such as most cancers, an individual's environment plays a large role in determining whether or not the individual eventually develops the disease. Some individuals who have disease gene sequences develop diseases, while others who carry the exact same disease gene sequences do not. One purpose of collecting environmental data about individuals whose gene sequences are studied is to effectively rule out any non-genetic causes of disease. Another purpose is to discover if any individuals who are carrying disease gene sequences but who do not develop the disease have other compensatory gene sequences or factors which enable them to live disease-free.
- To a certain extent, the second group of genomics companies do take into account a small amount of environmental data when they select individuals whose DNA they use for positional cloning analyses. The environmental data is usually in the form of a questionnaire or survey. However, the data is typically limited in scope to lifestyle questions, and is used only to help narrow the search for the specific disease gene in question.
- In addition, most genomics companies are reluctant to share their data on individuals with others, even those genomics companies which are studying the same gene sequences. As a result, each genomics company must gather its own data on individuals having a certain disease. For example, Sequana sent its own researcher to the island of Tristan de Cunha to study hereditary asthma, while Myriad is located in Salt Lake City to take advantage of the detailed family trees of the Mormons. For genomics companies searching for gene sequences, gathering environmental data on individuals is often an expensive, time-consuming, but necessary step. Genomics companies could potentially spend more of their time and money on actual disease gene isolation if they were able to obtain necessary environmental data from &other source.
- Another problem lies in the fact that when genomics companies do gather environmental data on the individuals whose gene sequences are studied, the environmental data represents only a small time frame of an individual's life. Few genomics companies continually collect data over a long period of time, and as a result, are not able to definitively rule out certain environmental factors which may affect disease progression. In addition, such data collections are unlikely to provide leads for factors which may prohibit the formation of disease.
- Accordingly, it is a primary object of the present invention to provide a system and method for creating a database of information about individuals' environments over a period of time. Another object of the present invention is to provide a database containing information about individuals' environments which can be used with existing genomics databases. A further object of the present invention is to provide a method of using environmental information about an individual in conjunction with the individual's genotype to find disease-influencing genes or substances. It is another object of the present invention to use the disease-influencing genes or substances to find drug candidates or drug targets.
- These objects and advantages are attained by a system and method for identifying a disease-influencing gene or protein. The method includes the step of selecting individuals having d risk factor for a certain disease. Each of the individuals is provided with a remotely programmable apparatus having a user interface for communicating queries to the individuals and for receiving responses. Each apparatus also includes a communication device, such as a modem, for communicating with a server through a communication network.
- Queries relating to the individuals' environment are entered into the server and transmitted from the server to each individual's remote apparatus. After the individuals have responded to the queries, the responses are sent back to the server and organized into a database. Data mining software is then used to distinguish the individuals into groups based on their environmental profiles. After a period of time, each group is then further divided into categories based on their disease progression. The genomes of all the individuals are then sequenced. Data mining techniques are used to find gene differences between the categories.
- According to a second method of the invention, the individuals are first separated into groups according to their disease progressions. Data mining techniques are then used to further distinguish each group into categories based on the individuals' environmental profiles. The genomes of all the individuals are then sequenced, and data mining techniques are used to find gene differences between the categories.
- A third embodiment of the invention provides a method for identifying disease-influencing substances. The method includes the step of selecting individuals having a risk factor for a certain disease. Each of the individuals is provided with a remotely programmable apparatus having a user interface for communicating queries to the individuals and for receiving responses. Each apparatus also includes a communication device, such as a modem, for communicating with a server through a communication network.
- Queries relating to the individuals' environment are entered into the server and transmitted from the server to each individual's remote apparatus. After the individuals have responded to the queries, the responses are sent back to the server and organized into a database. The genomes of all the individuals are then sequences. The individuals are placed into groups based on their gene sequences. Each group is then separated into categories based on the individuals' disease progression. Data mining techniques are then used to find a disease-influencing substance between the categories of individuals by using the individuals environmental profiles.
- The disease influencing gene or substance isolated using these methods is preferably, used to develop drug candidates or drug targets. Additionally, the isolation of the disease-influencing gene is preferably used to identify a corresponding disease-influencing protein, which can also be used to develop drug candidates or drug targets.
- The present invention also provides a database and data processing system for storing and analyzing environmental information about individuals. The database and data processing system comprise a server for storing queries and the individuals' responses to the queries. The system also includes at least one remotely programmable apparatuses having a user interface for communicating queries to the individuals and for receiving the responses. Each apparatus also includes a communication device, such as a modem, for communicating with the server through a communication network.
- The system also includes genotyping means in communication with the server for determining the individuals' gene sequences and a data mining software program accessible to the server for analyzing the individuals gene sequences and environmental profiles. In particular, the data mining program includes: means for analyzing the responses in order to group the individuals having a similar behavioral and environmental profile, a similar disease progression, and a similar genotype; means for analyzing the responses in order to group the individuals having a similar disease progression; means for analyzing the responses in order to group the individuals having a similar genotype; and means for identifying a disease-influencing gene or substance. Alternatively, the database can be used with other genomics or bioinformatics databases and systems if the information is to be manipulated in different ways.
-
FIG. 1 is a block diagram of a networked system according to a preferred embodiment of the invention. -
FIG. 2 is a block diagram illustrating the interaction of the components of the system ofFIG. 1 . -
FIG. 3 is a perspective view of a remotely programmable apparatus of the system ofFIG. 1 . -
FIG. 4 is a block diagram illustrating the components of the apparatus ofFIG. 3 . -
FIG. 5 is a script entry screen according to the preferred embodiment of the invention. -
FIG. 6A is a listing of a sample script program according to the preferred embodiment of the invention. -
FIG. 6B is a continuation of the listing ofFIG. 6A . -
FIG. 7 is a script assignment screen according to the preferred embodiment of the invention. -
FIG. 8 is a sample query appearing on a display of the apparatus ofFIG. 3 . -
FIG. 9 is a sample prompt appearing on the display of the apparatus ofFIG. 3 . -
FIG. 10 is a sample report displayed on a workstation of the system ofFIG. 1 . -
FIG. 11A is a flow chart illustrating the steps included in a monitoring application executed by the server ofFIG. 1 according to the preferred embodiment of the invention. -
FIG. 11A is a continuation of the flow chart ofFIG. 11B . -
FIG. 12A is a flow chart illustrating the steps included in the script program ofFIGS. 6A-6B . -
FIG. 12B is a continuation of the flow chart ofFIG. 12A . -
FIG. 13 is a sample data table of the present invention. -
FIG. 14 is a sample completed data table of the present invention. -
FIG. 15 is a flow chart illustrating a first method for identifying a gene according to the present invention. -
FIG. 16 is a block diagram illustrating the method ofFIG. 15 . -
FIG. 17 is a flow chart illustrating a second method for identifying a gene according to the present invention. -
FIG. 18 is a block diagram illustrating the method ofFIG. 17 . -
FIG. 19 is a flow chart illustrating a third method according to the present invention. -
FIG. 20 is a block diagram illustrating the method ofFIG. 19 . - The invention presents a system and method for creating a database containing environmental information about an individual to be used in conjunction with the individual's gene sequences to find new drug targets and drug candidates. In a preferred embodiment of the invention, remote monitors are used to collect the environmental information. It is to be understood that environmental information includes all non-genetic information about an individual, such as disease progression, diet, lifestyle, and geographical location.
- A preferred embodiment of the invention is illustrated in
FIGS. 1-16 . Referring toFIG. 1 , a networked system includes aserver 50 and aworkstation 52 connected toserver 50 through acommunication network 58.Server 50 is also connected to apatient profile database 54 which stores environmental information about the individuals.Server 50 is further connected to agenotyping system 56 which is capable of sequencing individuals' genomes.Patient profile database 54 andgenotyping system 56 are connected toserver 50 throughcommunication network 58. -
Server 50 andpatient profile database 54 are preferably world wide web servers.Server 50 anddatabase 54 may comprise single stand-alone computers or multiple computers distributed throughout a network.Workstation 52 is preferably a personal computer, remote terminal, or web TV unit.Workstation 52 functions as a remote interface for entering inserver 50 messages and queries to be communicated to the individuals. -
Genotyping system 56 can be a laboratory capable of sequencing individuals' genomes, a gene sequencing chip such as the Genechip by Affymetrix, or any other suitable genotyping system.Genotyping system 56 should be capable of transmitting information about the individuals' genomes toserver 50.Communication network 58 connectsworkstation 52,patient profile database 54, andgenotyping system 56 toserver 50.Communication network 58 can be any suitable communication network, such as a telephone cable, the Internet, or cellular or wireless communication. Such communication networks are well known in the art. - The system also includes remotely
programmable apparatuses 60 for monitoring individuals. Preferably, eachremote apparatus 60 is used to monitor a respective one of the individuals. Alternatively a multi-user apparatus may be used to monitor a plurality of individuals. Each remote apparatus is designed to interact with an individual in accordance with script programs received fromserver 50. - Each remote apparatus is in communication with
server 50 thoughcommunication network 58, which is preferably the Internet. Alternatively, each remote apparatus may be placed in communication with the server via telephone cable, cellular communication, wireless communication, etc. For clarity of illustration, only two remote apparatuses are shown inFIG. 1 . It is to be understood that the system may include any number of remote apparatuses for monitoring any number of individuals. - In the preferred embodiment, each individual to be monitored is also provided with a
monitoring device 64.Monitoring device 64 is designed to produce measurements of a physiological condition of the individual, record the measurements, and transmit the measurements to the individual'sremote apparatus 60 through astandard connection cable 62. Examples of suitable monitoring devices include blood glucose meters, respiratory flow meters, blood pressure cuffs, electronic weight scales, and pulse rate monitors. Such monitoring devices are well known in the art. - The specific type of monitoring device provided to each individual is dependent upon the individual's disease. For example, diabetes patients are provided with blood glucose meters for measuring blood glucose concentrations, asthma patients are provided with respiratory flow meters for measuring peak flow rates, obesity patients are provided with weight scales, etc.
-
FIG. 2 showsserver 50,workstation 52, andremote apparatus 60 in greater detail.Server 50 includes adatabase 66 for storingscript programs 68. The script programs 68 are executed by eachremote apparatus 60 to communicate queries and messages to an individual, receiveresponses 70 to the queries, collectmonitoring device measurements 72, and transmitresponses 70 andmeasurements 72 toserver 50.Database 66 is designed to store theresponses 70 andmeasurements 72.Database 66 further includes a look-up table 74. Table 74 contains a list of the individuals to be monitored, and for each individual, a unique-individual identification code and a respective pointer to scriptprogram 68 assigned to the individual. Eachremote apparatus 60 is designed to execute the assigned script program which it receives fromserver 50. -
FIGS. 3-4 show the structure ofremote apparatus 60 according to the preferred embodiment. Referring toFIG. 3 ,remote apparatus 60 includes ahousing 90.Housing 90 is preferably sufficiently compact to enable the remote apparatus to be handheld and carried by an individual.Remote apparatus 60 also includes a user interface for communicating queries to the individual and for receiving responses to the queries. - In the preferred embodiment, the user interface includes a
display 92 and fouruser input buttons Display 92 displays queries and prompts to the individual, and is preferably a liquid crystal display (LCD). Theuser input buttons remote apparatus 60. For example, the user input buttons may be replaced by switches, keys, a touch sensitive display screen, or any other data input device. Alternatively, the display and input buttons may be replaced by a speech synthesis/speech recognition interface. - Three monitoring device jacks 96A, 96B, and 96C are located on a surface of
housing 90. Device jacks 96A, 96B, and 96C are for connectingremote apparatus 60 to a number of monitoring devices, such as blood glucose meters, respiratory flow meters, or blood pressure cuffs, through standard connection cables (not shown). Theapparatus 60 also includes amodem jack 94 for connectingremote apparatus 60 to a telephone jack through a standard connection cord (not shown).Remote apparatus 60 further includes a visual indicator, such as a light emitting diode (LED) 100.LED 100 is for visually notifying the individual that he or she has unanswered queries stored inremote apparatus 60. -
FIG. 4 is a schematic block diagram illustrating the components ofremote apparatus 60 in greater detail.Remote apparatus 60 includes amicroprocessor 102 and amemory 108 connected tomicroprocessor 102.Memory 108 is preferably a non-volatile memory, such as a serial EEPROM.Memory 108 stores script programs received from the server, measurements received from monitoringdevice 64, responses to queries, and the individual's unique identification code.Microprocessor 102 also includes built-in read-only memory (ROM) which, stores firmware for controlling the operation ofremote apparatus 60. The firmware includes a script interpreter used bymicroprocessor 102 to execute the script programs. The script interpreter interprets script commands which are executed bymicroprocessor 102. Specific techniques for interpreting and executing script programs in this manner are well known in the art. -
Microprocessor 102 is preferably connected tomemory 108 using a standard two-wire I2C interface.Microprocessor 102 is also connected touser input buttons LED 100, aclock 112, and adisplay driver 110.Clock 112 indicates the current date and time tomicroprocessor 102. For clarity of illustration,clock 112 is shown as a separate component, but is preferably built intomicroprocessor 102.Display driver 110 operates under the control ofmicroprocessor 102 to display information ondisplay 92.Microprocessor 102 is preferably a PIC 16C65 processor which includes a universal asynchronous receiver transmitter (UART) 104.UART 104 is for communicating with amodem 114 and adevice interface 118. ACMOS switch 116 under the control ofmicroprocessor 102 alternately connectsmodem 114 andinterface 118 toUART 116. -
Modem 114 is connected to atelephone jack 119 throughmodem jack 94.Modem 114 is for exchanging data with the server through the communication network. The data includes script programs which are received from the server as well as responses to queries, device measurements, script identification codes, and the individual's unique identification code whichmodem 114 transmits toserver 50.Modem 114 is preferably a complete 28.8 K modem commercially available from Cermetek, although any suitable modem may be used. -
Device interface 118 is connected todevice jacks Device interface 118 is for interfacing with a number of monitoring devices, such as blood glucose meters, respiratory flow meters, blood pressure cuffs, weight scales, or pulse rate monitors, throughdevice jacks Device interface 118 operates under the control ofmicroprocessor 102 to collectmeasurements 72 frommonitoring devices 64 and tooutput measurements 72 tomicroprocessor 102 for storage inmemory 108. In the preferred embodiment,interface 118 is a standard RS232 interface. For simplicity of illustration, only onedevice interface 118 is shown inFIG. 4 . However, in alternative embodiments,remote apparatus 60 may include multiple device interfaces to accommodate monitoring devices which have different connection standards. - Referring again to
FIG. 2 ,server 50 includes amonitoring application 76. Monitoringapplication 76 is a controlling software application executed byserver 50 to perform the various functions described below. Monitoringapplication 76 includes ascript generator 78, ascript assignor 80, and areport generator 82.Script generator 78 is designed to generatescript programs 68 from script information entered throughworkstation 52. The script information is entered through ascript entry screen 84. In the preferred embodiment,script entry screen 84 is implemented as a web page on theserver 50.Workstation 52 includes a web browser for accessing the web page to enter the script information. -
FIG. 5 illustratesscript entry screen 84 as it appears onworkstation 52.Script entry screen 84 includes ascript name field 120 for specifying the name of script program to be generated.Screen 84 also includes entry fields 122 for entering a set of queries to be answered by an individual. Eachentry field 122 has corresponding response choice fields 124 for entering response choices for the query.Screen 84 further includescheck boxes 126 for selecting a desired monitoring device type from which to collect measurements, such as a blood glucose meter, respiratory flow meter, or blood pressure cuff. -
Screen 84 additionally includes aconnection time field 128 for specifying a prescribed connection time at which each remote apparatus executing the script program is to establish a subsequent communication link to the server. The connection time is preferably selected to be the time at which communication rates are the lowest, such as 3:00 AM.Screen 84 also includes aCREATE SCRIPT button 130 for instructing the script generator to generate a script program from the information entered inscreen 84.Screen 84 further includes a CANCELbutton 132 for canceling the information entered. - In the preferred embodiment, each script program created by the
script generator 82 conforms to the standard file format used on UNIX systems. In the standard file format, each command is listed in the upper case and followed by a colon. Every line in the script program is terminated by a linefeed character {LF}, and only one command is placed on each line. The last character in the script program is a UNIX end of file character {EOF}. TABLE 1 shows an exemplary listing of script commands used in the preferred embodiment of the invention.Command Description CLS: {LF} Clear the display ZAP: {LF} Erase from memory the last set of query responses recorded. LED: b{LF} Turn the LED on or off, where b is a binary digit of 0 or 1. An argument of 1 turns on the LED, and an argument of 0 turns off the LED. DISPLAY: (chars) {LF} Display the text following the DISPLAY command INPUT: mmmm{LF} Record a button press. The m's represent a button mask pattern for each of the four input buttons. Each m contains an “X” for disallowed buttons or an “0” for allowed buttons., For example, INPUT: OXOX{LF) allows the user to press either button # 1 or #3.WAIT {LF} Wait for any one button to be pressed, then continue executing the script program. COLLECT: device{LF1} Collect measurements from the monitoring device specified in the COLLECT command. The user is preferably prompted to connect the specified monitoring device to the apparatus and press a button to continue. NUMBER: aaaa{LF} Assign a script identification code to the script program. The script identification code ‘from the most recently executed NUMBER statement is subsequently transmitted to the server along with the query responses and device measurements. The script identification code identifies to the server which script program was most recently executed by the-remote apparatus. DELAY: t {LF} Wait until time t specified in the DELAY command, usually the prescribed connection time. CONNECT: {LF} Perform a connection routine to establish a communication link to the server, transmit the patient identification code, query responses, device measurements, and script identification code to the server, and receive and store a new script program, When the server instructs the apparatus to disconnect, the script interpreter is restarted, allowing the new script program to execute. - The script commands illustrated in TABLE 1 are representative of the preferred embodiment and are not intended to limit the scope of the invention. After consideration of the ensuing description, it will be apparent to one skilled in the art many other suitable scripting languages and sets of script commands may be used to implement the system and method of the invention.
-
Script generator 78 preferably stores a script program template which it uses to create each script program. To generate a script program,script generator 78 inserts into the template the script information entered inscript entry screen 84. For example,FIGS. 6A-6B illustrate a sample script program created by the script generator from the script information shown inFIG. 5 . - The script program includes display commands to display the queries and response choices entered in
fields check boxes 126. The script program also includes commands to establish a subsequent communication link to the server at the connection time specified infield 128. The steps included in the sample script program are also shown in the flow chart ofFIGS. 12A-12B and will be discussed in the operation section below. - Referring again to
FIG. 2 ,script assignor 80 is for assigning thescript programs 68 to the individuals. The script programs are assigned in accordance with script assignment information entered throughworkstation 52. The script assignment information is entered through ascript assignment screen 86, which is preferably implemented as a web page onserver 50. -
FIG. 7 shows a samplescript assignment screen 86 as it appears on the workstation.Screen 86 includescheck boxes 134 for selecting the script program to be assigned and checkboxes 136 for selecting the individuals to whom the script program is to be assigned.Screen 86 also includes an ASSIGNSCRIPT button 140 for entering the assignments. Whenbutton 140 is pressed, the script assignor creates and stores for each individual selected in check boxes 136 a respective pointer to the script program selected incheck boxes 134. Each pointer is stored in the look-up table 74 ofdatabase 66.Screen 86 further includes anADD SCRIPT button 138 for accessing the script entry screen and aDELETE SCRIPT button 142 for a deleting script program. - Referring again to
FIG. 2 ,report generator 82 is designed to generate areport 88 from theresponses 70 anddevice measurements 72 received inserver 50.Report 88 is displayed onworkstation 52.FIG. 10 shows asample patient report 88 produced byreport generator 82 for a selected individual.Report 88 includes agraph 146 of the device measurements received from the individual, as well as a listing of the query responses received from the individual. Specific techniques for writing a report generator program to display data in this manner are well known in the software art. - The operation of the preferred embodiment is illustrated in
FIGS. 1-12 .FIG. 11A is a flow chart illustrating steps included in the monitoring application executed byserver 50.FIG. 11B is a continuation of the flow chart ofFIG. 11A . Instep 202, the server determines if new script information has been entered throughscript entry screen 84. If new script information has not been entered, the server proceeds to step 206. If new script information has been entered, the server proceeds to step 204. - As shown in
FIG. 5 , the script information includes a set of queries, and for each of the queries, corresponding responses choices. The script information also includes a selected monitoring device type from which to collect measurements. The script information further includes a prescribed connection time for each remote apparatus to establish a subsequent communication link to the server. The script information is generally entered in the server by a healthcare provider, such as the individuals' physician or case manager. Of course, any person desiring to communicate with the individual may also be granted access to the server to create and assign script programs. Further, it is to be understood that the system may include any number of workstations for entering script generation and script assignment information into the server. - In
step 204,script generator 78 generates a script program from the information entered inscreen 84. The script program is stored indatabase 66.Steps script entry screen 84. Followingstep 204, the server proceeds to step 206. - In
step 206, the server determines if new script assignment information has been entered throughscript assignment screen 86. If new script assignment information has not been entered, the server proceeds to step 210. If new script assignment information has been entered, the server proceeds to step 208. As shown inFIG. 7 , script programs are assigned to each individual by selecting a script program throughcheck boxes 134, selecting the individuals to whom selected the script program is to be assigned throughcheck boxes 136, and pressing the ASSIGNSCRIPT button 140. Whenbutton 140 is pressed,script assignor 86 creates for each individual selected in check boxes 136 a respective pointer to the script program selected incheck boxes 134. Instep 208, each pointer is stored in look-up table 74 ofdatabase 66. Followingstep 208, the server proceeds to step 210. - In
step 210, the server determines if any of the remote apparatuses are remotely connected to the server. Each individual to be monitored is preferably provided with his or her own remote apparatus which has the individual's unique identification code stored therein. Each individual is thus uniquely associated with a respective one of the remote apparatuses. If none of remote apparatuses are connected, the server proceeds to step 220. - If a remote apparatus is connected, the server receives from the apparatus the individual's unique identification code in
step 212. Instep 214, the server receives from the apparatus the query responses, device measurements, and script identification code recorded during execution of a previously assigned script program. The script identification code identifies to the server which script program was executed by the remote apparatus to record the query responses and device measurements. The responses, device measurements, and script identification code are stored indatabase 66. - In
step 216, the server uses the individual's unique identification code to retrieve from look-up table 74 the pointer to the script program assigned to the individual. The server then retrieves the assigned script program from thedatabase 66. Instep 218, the server transmits the assigned script program to the individual's remote apparatus through thecommunication network 58. Followingstep 218, the server proceeds to step 220. - In
step 220, the server determines if a report request has been received fromworkstation 52. If no report request has been received, the server returns to step 202. If a report request has been received for a selected individual, the server retrieves fromdatabase 66 the query responses and measurements last received from the individual,step 222. Instep 224, the server generates and displays thereport 88 onworkstation 52. - As shown in
FIG. 10 , the report includes the query responses and device measurements last received from the individual. Followingstep 224, the server returns to step 202. -
FIGS. 12A-12B illustrate the steps included in a sample script program executed by the remote apparatus. Before the script program is received, the remote apparatus is initially programmed with the individual's unique identification code and the script interpreter used bymicroprocessor 102 to execute script programs. The initial programming may be achieved during manufacture or during an initial connection to the server. Following initial programming, the remote apparatus receives from the server the script program assigned to the individual associated with the apparatus. The script program is received bymodem 114 through a first communication link to the server and stored inmemory 108. - In
step 302,microprocessor 102 assigns a script identification code to the script program and stores the script identification code inmemory 108. The script identification code is subsequently transmitted to the server along with query responses and device measurements to identify to the server which script program was most recently executed by the remote apparatus. Instep 304,microprocessor 102 lights LED 100 to notify the individual that he or she has unanswered queries stored in the remote apparatus.LED 100 preferably remains lit until the queries are answered by the individual. Instep 306,microprocessor 102 erases frommemory 108 the last set of query responses recorded. - In
step 308,microprocessor 102 prompts the individual by displaying ondisplay 92 “ANSWER QUERIES NOW? PRESS ANY BUTTON TO START”. In step 310,microprocessor 102 waits until a reply to the prompt is received from the individual. When a reply is received,microprocessor 102 proceeds to step 312. Instep 312,microprocessor 102 executes successive display and input commands to display the queries and response choices ondisplay 92 and to receive responses to the queries. -
FIG. 8 illustrate a sample query and its corresponding response choices as they appear ondisplay 92. The response choices are preferably positioned ondisplay 92 such that each response choice is located proximate a respective one of theuser input buttons microprocessor 102 stores the response inmemory 108. - In
steps 314 to 318,microprocessor 102 executes commands to collect device measurements from a selected monitoring device specified in the script program. Instep 314,microprocessor 102 prompts the individual to connect the selected device to one of the device jacks 96A, 96B, or 96C. A sample prompt is shown inFIG. 9 . In step 316,microprocessor 102 waits until a reply to the prompt is received from the individual. When a reply is received,microprocessor 102 proceeds to step. 318.Microprocessor 102 also connectsUART 104 todevice interface 118 throughCMOS switch 116. Instep 318,microprocessor 102 collects device measurements from the selected device throughdevice interface 118. The device measurements are stored inmemory 108. - In
step 320,microprocessor 102 prompts the individual to connectremote apparatus 60 totelephone jack 119 so that the apparatus may connect to the server at the prescribed connection time. Instep 322,microprocessor 102 waits until a reply to the prompt is received from the individual. When a reply is received,microprocessor 102 turns offLED 100 instep 324. Instep 326,microprocessor 102 waits until it is time to connect to the server.Microprocessor 102 compares the connection time specified in the script program to the current time output byclock 112. When it is time to connect,microprocessor 102 connectsUART 104 tomodem 114 throughCMOS switch 116. - In
step 328,microprocessor 102 establishes a subsequent communication link betweenremote apparatus 60 andserver 50 throughmodem 114 andcommunication network 58. If the connection fails for any reason,microprocessor 102 repeats step 328 to get a successful connection. Instep 330,microprocessor 102 transmits the query responses, device measurements, script identification code, and the individual's unique identification code stored inmemory 108 to the server. Instep 332,microprocessor 102 receives through modem 114 a newly assigned script program from the server. The new script program is stored inmemory 108 for subsequent execution bymicroprocessor 102. Followingstep 332, the script program ends. - After the individual's information has been collected via
remote apparatus 60 and the script programs, the data is mined to distinguish patterns. Data mining programs are well known in the art and can be easily adapted to this system. In the preferred embodiment, the data mining program includes a data table 150, as shown inFIG. 13 . Data table 150 is stored on the server and has an individualidentification number field 151, name fields 152, value fields 154 corresponding to the name fields, andexplanation fields 156 corresponding to the name fields and value fields. The data type is entered into name fields 152, the possible numerical values corresponding to the data type are entered intovalue fields 154, and brief explanations of the data types and corresponding values are entered into explanation fields 156. - The individuals' device measurements and responses to the queries are entered into data table 150 in the form of numerical values in value fields 154. The individual's identification number is entered into individual
identification number field 151. An example of data table 150 in which the individuals' information has been entered is shown inFIG. 14 . Once data table 150 contains all the necessary information, the data mining program then compares the information. -
FIG. 15 is a flowchart illustrating a first method of the present invention carried out by the server using the data mining techniques described above. Instep 400, individuals having a risk factor for a disease are selected. Instep 402, these individuals are queried about their behavior and environment using the script programs and remote apparatuses previously described. The responses to the queries and any device measurements are received and stored by the server. Collection of the responses and device measurements can occur over any period of time, thus allowing for more accurate data. - After the server receives the responses and measurements, a database comprising the individuals' behavioral and environmental profiles is created in
step 404. Instep 406, data mining techniques are used to group individuals having similar behavioral and environmental profiles. Instep 408, the server determines if it is necessary to further group the individuals in order to produce smaller groups.Steps - In
step 410, each group of individuals is categorized using data mining techniques. The individuals are categorized according to their disease progressions. For example, a group of individuals can be categorized into those that have a severe disease phenotype, those that have a moderate disease phenotype, and those that have a mild disease phenotype. Instep 412, the server determines if it is necessary to further categorize the individuals.Steps - In
step 414, the genomes of all the individuals are sequenced by genotypingsystem 56. The genotypes of all the individuals are transmitted toserver 50. Instep 416, data mining techniques are used to compare the genotypes of the individuals between the categories. For example, if those individuals who have a severe disease phenotype and are overweight have a certain gene sequence, while those individuals who have a mild disease phenotype and are overweight do not, it is likely the gene sequence is responsible for the severe disease phenotype. If a gene sequence is found, it is further identified instep 418. Methods of isolating and identifying gene sequences are well known in the field. -
FIG. 16 is a block diagram illustrating an example of the first method of the present invention as described inFIG. 15 . First individuals having a risk factor for a certain disease, such as non-insulin dependent diabetes mellitus (NIDDM), are selected, as indicated atblock 422. Behavioral and environmental information from each individual is collected using the script programs and remote apparatuses. Using data mining techniques, the individuals are then grouped intooverweight individuals 424 andnon-overweight individuals 426. Using data mining techniques, the individuals are then categorized into overweight individuals havingsevere NIDDM 428, overweight individuals havingmild NIDDM 430, non-overweight individuals havingmild NIDDM 432, and non-overweight individuals havingsevere NIDDM 434. - The individuals' genotype information is then taken, as indicated at
block 436, to determine the individuals' gene sequences. For example, overweight individuals with severe NIDDM have gene sequence A, overweight individuals with mild NIDDM have gene sequence B, non-overweight individuals with mild NIDDM have gene sequence B, and non-overweight individuals with severe NIDDM have gene sequence A. Data mining techniques are then used to analyze the information and come to a conclusion. In this example, data mining would conclude that the severe NIDDM phenotype is likely related to gene sequence A, not the individual's weight. -
FIG. 17 shows a flowchart illustrating a second method of the present invention carried out by the server using the data mining techniques described above. Instep 500, individuals having a risk factor for a disease are selected. Instep 502, these individuals are queried about their behavior and environment using the script programs and remote apparatuses previously described. The responses to the queries and any device measurements are received and stored by the server. - After the server receives the responses and measurements from the remote apparatuses, a database comprising the individuals' behavioral and environmental profiles is created in
step 504. Instep 506, data mining techniques are used to group together individuals having similar disease progressions. For example, a group of individuals can be grouped into those that have a severe disease phenotype, those that have a moderate, disease phenotype, and those that have a mild disease phenotype. Instep 508, the server determines if it is necessary to further group the individuals in order to produce smaller groups.Steps - In
step 510, each group of individuals created insteps step 512 the server determines if it is necessary to further group the individuals in order to produce smaller groups.Steps - In
step 514, the genomes of all the individuals are sequenced by genotypingsystem 56. The genotypes of all the individuals are transmitted to the server. Instep 516, data mining techniques are used to compare the genotypes of the individuals between the categories. For example, if those individuals who have a severe disease phenotype and are overweight have a certain gene sequence, while those individuals who have a mild disease and are also overweight phenotype do not, it is likely the gene sequence, not weight; is responsible for the severe disease phenotype. If a gene sequence is found, it is further identified instep 518. Specific techniques of isolating and identifying gene sequences are well known in the field. -
FIG. 18 is a block diagram illustrating an example of the second method of the present invention as described inFIG. 17 . First individuals having a risk factor for a certain disease, such as NIDDM, are chosen, as indicated atblock 522. Behavioral and environmental information from each individual is collected using the remote apparatuses and script programs. Using data mining techniques, the individuals are then grouped into those exhibitingsevere NIDDM 524 and those exhibitingmild NIDDM 526. Using data mining techniques, the individuals are then categorized into overweight individuals havingsevere NIDDM 528, non-overweight individuals havingsevere NIDDM 530, non-overweight individuals havingmild NIDDM 532, and overweight individuals havingmild NIDDM 534. - The individuals' genotype information is then taken, as indicated at
block 536, to determine the individuals' gene sequences. For example, individuals with severe NIDDM who are overweight have gene sequence A, individuals with severe NIDDM who are non-overweight have gene sequence A, individuals with mild NIDDM who are non-overweight have gene sequence B, and individuals with severe NIDDM who are overweight have gene sequence B. Data mining techniques are then used to analyze the information and come to a conclusion. In this example, data mining would conclude that the severe NIDDM phenotype is likely related to gene sequence A, not the individual's weight. -
FIG. 19 shows a flowchart illustrating a preferred method carried out byserver 50 to identify a disease-identifying substance. Instep 600, individuals having a risk factor for a disease are selected. Instep 602, these individuals are queried about their behavior and environment using the script programs and remote apparatuses previously described. The responses to the queries and any device measurements are received and stored by the server. - After the server receives the responses and measurements from the remote apparatuses, a database comprising the individuals' behavioral and environmental profiles is created in
step 604. Instep 606, the genomes of all the individuals are sequenced, and the genotypes of all the individuals are transmitted to the server. Instep 608, individuals having the same or close genotypes are grouped together. Instep 610, data mining techniques are used to categorize together individuals, having similar disease progressions. Instep 612, the server determines if it is necessary to further categorize the individuals in order to produce smaller groups.Steps - In
step 614, data mining techniques are used to find a disease influencing substance between the categories of individuals by using the individuals behavioral and environmental profiles. For example, if those individuals who have a severe disease phenotype are overweight, while those individuals who have a mild disease phenotype are not, it is likely weight is responsible for the severe disease phenotype. If such a disease-influencing substance is found, it is identified in step 618. If no disease-influencing substance is found, the process is preferably repeated. -
FIG. 20 is a block diagram illustrating an example of the method described inFIG. 19 . First, individuals having a risk factor for a certain disease, such as NIDDM, are chosen, as indicated atblock 620. Behavioral and environmental information from each individual is collected using the remote apparatuses and script programs. The individuals' genotype information is then taken, as indicated atblock 622, to determine the individuals' gene sequences. The individuals are then grouped according to their gene sequences. For example, one group may have gene sequence A, as indicated atblock 624, while another group may have gene sequence B, as indicated atblock 626. Using data mining techniques, the individuals are then categorized into individuals with gene sequence A havingsevere NIDDM 628, individuals with gene sequence A havingmild NIDDM 630, individuals with gene sequence B havingmild NIDDM 632, and individuals with gene sequence B havingsevere NIDDM 634. - Data mining techniques are further used to analyze the categories of individuals and their behavioral and environmental profiles. For example,
overweight individuals 638 with severe NIDDM have gene sequence A,non-overweight individuals 640 with mild NIDDM have gene sequence A,overweight individuals 642 with mild NIDDM have gene sequence B, andnon-overweight individuals 644 with severe NIDDM have gene sequence B. Data mining techniques are then used to analyze the information and come to a conclusion. In this example, data mining would conclude that the severe NIDDM phenotype is likely related to gene sequence A, not the individual's weight. - Although the above description contains many specificities, these should not be construed as limitations on the scope of the invention but merely as illustrations of some of the presently preferred embodiments. Many other embodiments of the invention are possible. For example, the scripting language and script commands shown are representative of the preferred embodiment. It will be apparent to one skilled in the art that many other scripting languages and specific script commands may be used to implement the invention.
- Moreover, the invention is not limited to the specific applications described. The system and method of the invention have many other applications. For example pharmaceutical manufacturers may apply the system in clinical trials to analyze new drug data.
- Therefore, the scope of the invention should be determined by the appended claims and their legal equivalents.
Claims (31)
1-29. (canceled)
30. A method of correlating responses from a group of individuals comprising:
a) selecting individuals having a risk factor for a disease;
b) creating queries regarding the individuals symptoms, behaviors, or environments;
c) storing the queries on a server;
d) transmitting the queries from the server to a remotely programmable apparatus identified with each individual, said remotely programmable apparatus having a user interface for communicating queries and for receiving responses, and having a communications function for communicating with the server through a communications network;
e) transmitting the responses of the individuals to the queries from the remotely programmable apparatuses to the server; and
f) creating a database of the individuals' symptoms, behavior or environments.
31. The method of claim 30 , wherein the queries are scripted and are adjustable to each individual.
32. The method of claim 30 , further comprising adjusting the queries to the individual with a script generator based upon the responses received from an individual.
33. The method of claim 32 , further comprising repeating the method with the adjusted queries.
34. The method of claim 30 , wherein the queries comprise factors associated with genetic information.
35. The method of claim 30 , wherein the responses from the individuals comprise phenotypic information.
36. The method of claim 35 , wherein said phenotypic information indicates some expression of nucleic acid sequence.
37. The method of claim 30 , wherein the communications apparatus is connectable with a monitoring device configured to acquire physiological data.
38. The method of claim 37 , wherein the monitoring device is selected from the group consisting of a blood glucose meter, a respiratory flow meter, a blood pressure cuff, a weight scale and a pulse meter.
39. A method of monitoring a group of individuals, comprising:
a) selecting individuals having a risk factor for a disease;
b) creating queries regarding the individuals symptoms, behaviors, or environments;
c) storing the queries on a server;
d) transmitting the queries from the server to a remotely programmable apparatus identified with each individual, said remotely programmable apparatus having a user interface for communicating queries and for receiving responses, and having a communications function for communicating with the server through a communications network;
e) transmitting the responses of the individuals to the queries from the remotely programmable apparatuses to the server;
f) creating a database of the individuals symptoms, behavior, or environments;
g) using data mining techniques to distinguish a group of individuals having similar symptoms, behavioral or environmental profiles; and
h) using statistical methods to categorize the individuals into one or more subgroups of individuals with similar symptom, behavioral, or environmental profiles.
40. The method of claim 39 , wherein the queries are scripted and are adjustable to each individual.
41. The method of claim 39 , further comprising adjusting the queries to the individual with a script generator based upon the responses received from an individual.
42. The method of claim 41 , further comprising repeating the method with the adjusted queries.
43. The method of claim 39 , wherein the queries comprise factors associated with genetic information.
44. The method of claim 39 , wherein the responses from the individuals comprise phenotypic information.
45. The method of claim 44 , wherein said phenotypic information indicates some expression of a nucleic acid sequence.
46. The method of claim 39 , wherein the communications apparatus is connectable with a monitoring device configured to acquire physiological data.
47. The method of claim 46 , wherein the monitoring device is selected from the group consisting of a blood glucose meter, a respiratory flow meter, a blood pressure cuff, a weight scale and a pulse meter.
48. The method of claim 39 , wherein the disease is selected from the group consisting of non-insulin dependent diabetes, sickle cell anemia, cystic fibrosis, asthma, malignant melanoma, breast cancer, ovarian cancer, colon cancer and obesity.
49. A method of determining the progression of a disease in an individual comprising:
a) selecting individuals diagnosed with a disease;
b) creating queries regarding the individuals symptoms, behaviors or environments;
c) storing the queries on a server;
d) transmitting the queries from the server to a remotely programmable apparatus identified with each individual, said remotely programmable apparatus having a user interface for communicating queries and for receiving responses, and having a communications function for communicating with the server through a communications network;
e) transmitting the responses of the individuals to the queries from the remotely programmable apparatuses to the server; and
f) creating a database of the individuals' symptoms, behavior or environments.
50. The method of claim 49 , wherein the queries are scripted and are adjustable to each individual.
51. The method of claim 49 , further comprising adjusting the queries to the individual with a script generator based upon the responses received from an individual.
52. The method of claim 49 , further comprising repeating the method with the adjusted queries.
53. The method of claim 49 , wherein the queries comprise factors associated with genetic information.
54. The method of claim 49 , wherein the responses from the individuals comprise phenotypic information related to the condition.
55. The method of claim 54 , wherein the phenotypic information is indicative of a genotypic condition.
56. The method of claim 55 , wherein said phenotypic information indicates some expression of a nucleic acid sequence.
57. The method of claim 49 , wherein the communications apparatus is connectable with a monitoring device configured to acquire physiological data.
58. The method of claim 57 , wherein the monitoring device is selected from the group consisting of a blood glucose meter, a respiratory flow meter, a blood pressure cuff, a weight scale and a pulse meter.
59. The method of claim 49 , wherein the disease is selected from the group consisting of non-insulin dependent diabetes, sickle cell anemia, cystic fibrosis, asthma, malignant melanoma, breast cancer, ovarian cancer, colon cancer and obesity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/359,437 US20060200319A1 (en) | 1997-03-28 | 2006-02-23 | System and method for identifying disease-influencing genes |
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4175197P | 1997-03-28 | 1997-03-28 | |
US4174697P | 1997-03-28 | 1997-03-28 | |
US08/847,009 US5897493A (en) | 1997-03-28 | 1997-04-30 | Monitoring system for remotely querying individuals |
US08/850,840 US5985559A (en) | 1997-04-30 | 1997-05-03 | System and method for preventing, diagnosing, and treating genetic and pathogen-caused disease |
US08/946,341 US5997476A (en) | 1997-03-28 | 1997-10-07 | Networked system for interactive communication and remote monitoring of individuals |
US4180998A | 1998-03-13 | 1998-03-13 | |
US37818899A | 1999-08-20 | 1999-08-20 | |
US09/496,893 US8078407B1 (en) | 1997-03-28 | 2000-02-02 | System and method for identifying disease-influencing genes |
US11/359,437 US20060200319A1 (en) | 1997-03-28 | 2006-02-23 | System and method for identifying disease-influencing genes |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US37818899A Continuation-In-Part | 1992-11-17 | 1999-08-20 | |
US09/496,893 Division US8078407B1 (en) | 1992-11-17 | 2000-02-02 | System and method for identifying disease-influencing genes |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060200319A1 true US20060200319A1 (en) | 2006-09-07 |
Family
ID=46203797
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/496,893 Expired - Fee Related US8078407B1 (en) | 1992-11-17 | 2000-02-02 | System and method for identifying disease-influencing genes |
US11/359,437 Abandoned US20060200319A1 (en) | 1997-03-28 | 2006-02-23 | System and method for identifying disease-influencing genes |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/496,893 Expired - Fee Related US8078407B1 (en) | 1992-11-17 | 2000-02-02 | System and method for identifying disease-influencing genes |
Country Status (1)
Country | Link |
---|---|
US (2) | US8078407B1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080228703A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Expanding Attribute Profiles |
US20090043752A1 (en) * | 2007-08-08 | 2009-02-12 | Expanse Networks, Inc. | Predicting Side Effect Attributes |
CN102831097A (en) * | 2011-05-27 | 2012-12-19 | 感芯科股份有限公司 | Cloud server for collecting physiological state information and observation system thereof |
USD694909S1 (en) | 2011-10-12 | 2013-12-03 | HealthSpot Inc. | Medical kiosk |
US8655915B2 (en) | 2008-12-30 | 2014-02-18 | Expanse Bioinformatics, Inc. | Pangenetic web item recommendation system |
US8996392B2 (en) | 2011-03-31 | 2015-03-31 | Healthspot, Inc. | Medical kiosk and method of use |
US9031870B2 (en) | 2008-12-30 | 2015-05-12 | Expanse Bioinformatics, Inc. | Pangenetic web user behavior prediction system |
US9043217B2 (en) | 2011-03-31 | 2015-05-26 | HealthSpot Inc. | Medical kiosk and method of use |
US20170214750A1 (en) * | 2016-01-21 | 2017-07-27 | Horiba, Ltd. | Management apparatus for measurement equipment |
US10223681B2 (en) | 2012-08-15 | 2019-03-05 | Rite Aid Hdqtrs. Corp. | Veterinary kiosk with integrated veterinary medical devices |
US11322227B2 (en) | 2008-12-31 | 2022-05-03 | 23Andme, Inc. | Finding relatives in a database |
US11410745B2 (en) * | 2018-06-18 | 2022-08-09 | International Business Machines Corporation | Determining potential cancer therapeutic targets by joint modeling of survival events |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10353869B2 (en) | 2012-05-18 | 2019-07-16 | International Business Machines Corporation | Minimization of surprisal data through application of hierarchy filter pattern |
US8972406B2 (en) * | 2012-06-29 | 2015-03-03 | International Business Machines Corporation | Generating epigenetic cohorts through clustering of epigenetic surprisal data based on parameters |
US9002888B2 (en) | 2012-06-29 | 2015-04-07 | International Business Machines Corporation | Minimization of epigenetic surprisal data of epigenetic data within a time series |
US9996889B2 (en) | 2012-10-01 | 2018-06-12 | International Business Machines Corporation | Identifying group and individual-level risk factors via risk-driven patient stratification |
US10395759B2 (en) | 2015-05-18 | 2019-08-27 | Regeneron Pharmaceuticals, Inc. | Methods and systems for copy number variant detection |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5660176A (en) * | 1993-12-29 | 1997-08-26 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system |
US6329139B1 (en) * | 1995-04-25 | 2001-12-11 | Discovery Partners International | Automated sorting system for matrices with memory |
Family Cites Families (364)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3426150A (en) | 1965-09-27 | 1969-02-04 | Lockheed Aircraft Corp | System for fm transmission of cardiological data over telephone lines |
US3581072A (en) | 1968-03-28 | 1971-05-25 | Frederick Nymeyer | Auction market computation system |
US3566365A (en) | 1968-09-12 | 1971-02-23 | Searle Medidata Inc | Multiphasic medical screening system |
US3566370A (en) | 1969-06-10 | 1971-02-23 | Searle Medidata Inc | Automated medical history taking system |
US4130881A (en) | 1971-07-21 | 1978-12-19 | Searle Medidata, Inc. | System and technique for automated medical history taking |
US3883235A (en) | 1971-09-17 | 1975-05-13 | John R Lynn | Automatic visual field examination including fixation monitoring compensation |
US3768014A (en) | 1972-01-28 | 1973-10-23 | Gen Electric | Cardiac pacemaker rate/interval computer system |
US3920005A (en) | 1972-03-16 | 1975-11-18 | Medtronic Inc | Evaluation system for cardiac stimulators |
JPS4928038A (en) | 1972-07-15 | 1974-03-13 | ||
US4004577A (en) | 1972-12-04 | 1977-01-25 | Survival Technology, Inc. | Method of treating heart attack patients prior to the establishment of qualified direct contact personal care |
US3910257A (en) | 1973-04-25 | 1975-10-07 | Nasa | Medical subject monitoring systems |
US4051522A (en) | 1975-05-05 | 1977-09-27 | Jonathan Systems | Patient monitoring system |
US3996928A (en) | 1975-05-28 | 1976-12-14 | Marx Alvin J | Patient vital-signs automated measuring apparatus |
US4412287A (en) | 1975-05-29 | 1983-10-25 | Braddock Iii Walter D | Automated stock exchange |
US4060915A (en) | 1976-08-02 | 1977-12-06 | Conway Malcolm J | Mental image enhancement apparatus utilizing computer systems |
US4151831A (en) | 1976-11-15 | 1979-05-01 | Safetime Monitors, Inc. | Fertility indicator |
US4150284A (en) | 1977-04-28 | 1979-04-17 | Texas Instruments Incorporated | Medical patient condition monitoring system |
US4151407A (en) | 1977-04-28 | 1979-04-24 | Texas Instruments Incorporated | Low-power, infrared information transmission system |
US4173971A (en) | 1977-08-29 | 1979-11-13 | Karz Allen E | Continuous electrocardiogram monitoring method and system for cardiac patients |
US4216462A (en) | 1978-03-06 | 1980-08-05 | General Electric Company | Patient monitoring and data processing system |
US4227526A (en) | 1978-04-13 | 1980-10-14 | Extracorporeal Medical Systems, Inc. | Mechanism for aurally instructing a patient and method |
US4958632A (en) | 1978-07-20 | 1990-09-25 | Medtronic, Inc. | Adaptable, digital computer controlled cardiac pacemaker |
US4270547A (en) | 1978-10-03 | 1981-06-02 | University Patents, Inc. | Vital signs monitoring system |
US4253521A (en) | 1978-10-23 | 1981-03-03 | Halliburton Company | Setting tool |
US4347568A (en) | 1978-12-07 | 1982-08-31 | Diamond Shamrock Corporation | Occupational health/environmental surveillance |
US4519398A (en) | 1979-07-09 | 1985-05-28 | Del Mar Avionics | Method and apparatus for long-term monitoring of physiological activity to provide a compact portable record |
US4296756A (en) | 1979-07-26 | 1981-10-27 | Cyber Diagnostics, Inc. | Remote pulmonary function tester |
US4422081A (en) | 1979-10-24 | 1983-12-20 | Del Mar Avionics | Validator for electrocardial data processing system |
US4259548A (en) | 1979-11-14 | 1981-03-31 | Gte Products Corporation | Apparatus for monitoring and signalling system |
US4417306A (en) | 1980-01-23 | 1983-11-22 | Medtronic, Inc. | Apparatus for monitoring and storing utilizing a data processor |
US4360345A (en) | 1980-07-14 | 1982-11-23 | American Heart Association, Inc. | Health education system |
US4347851A (en) | 1980-10-21 | 1982-09-07 | Norman S. Blodgett | Vital signs monitor |
US4449536A (en) | 1980-10-31 | 1984-05-22 | Sri International | Method and apparatus for digital data compression |
US4428733A (en) | 1981-07-13 | 1984-01-31 | Kumar Misir Victor | Information gathering system |
US4965825A (en) | 1981-11-03 | 1990-10-23 | The Personalized Mass Media Corporation | Signal processing apparatus and methods |
US4694490A (en) | 1981-11-03 | 1987-09-15 | Harvey John C | Signal processing apparatus and methods |
US4465077A (en) | 1981-11-12 | 1984-08-14 | Howard Schneider | Apparatus and method of determining fertility status |
US4473884A (en) | 1982-01-08 | 1984-09-25 | Sybron Corporation | Electronic medication dispensing system |
WO1983003744A1 (en) | 1982-04-23 | 1983-11-10 | Reinhold Herbert Edward Jr | Ambulatory monitoring system with real time analysis and telephone transmission |
US4518361A (en) | 1982-08-05 | 1985-05-21 | Conway Malcolm J | Method and apparatus for effecting and evaluating action upon visual imaging |
US4566461A (en) | 1983-02-15 | 1986-01-28 | Michael Lubell | Health fitness monitor |
US4576578A (en) | 1983-03-31 | 1986-03-18 | Bell & Howell Company | Interactive training apparatus |
FR2544525A1 (en) | 1983-04-12 | 1984-10-19 | Simatec Sarl | PORTABLE APPARATUS FOR SEIZING AND PROCESSING INFORMATION RELATING TO THE HEALTH OF A PERSON |
JPS60501695A (en) | 1983-06-29 | 1985-10-11 | マイケル・ゴ−ドン | Child hyperactivity test device |
US4546436A (en) | 1983-07-06 | 1985-10-08 | The Johns Hopkins University | Portable pH data collector |
US4722349A (en) | 1983-09-29 | 1988-02-02 | Zvi Halperin | Arrangement for and method of tele-examination of patients |
US4903201A (en) | 1983-11-03 | 1990-02-20 | World Energy Exchange Corporation | Automated futures trading exchange |
US4592546A (en) | 1984-04-26 | 1986-06-03 | David B. Lockton | Game of skill playable by remote participants in conjunction with a live event |
JPS6125525A (en) | 1984-07-13 | 1986-02-04 | 住友電気工業株式会社 | Patient monitor apparatus |
US4695954A (en) | 1984-10-31 | 1987-09-22 | Rose Robert J | Modular medication dispensing system and apparatus utilizing portable memory device |
US4712562A (en) | 1985-01-08 | 1987-12-15 | Jacques J. Ohayon | Outpatient monitoring systems |
US4627445A (en) | 1985-04-08 | 1986-12-09 | Garid, Inc. | Glucose medical monitoring system |
US4674652A (en) | 1985-04-11 | 1987-06-23 | Aten Edward M | Controlled dispensing device |
US4846797A (en) | 1985-05-14 | 1989-07-11 | Intelligent Medicine, Inc. | Syringe positioning device for enhancing fluid flow control |
US4835372A (en) | 1985-07-19 | 1989-05-30 | Clincom Incorporated | Patient care system |
US5111818A (en) | 1985-10-08 | 1992-05-12 | Capintec, Inc. | Ambulatory physiological evaluation system including cardiac monitoring |
US4838275A (en) | 1985-11-29 | 1989-06-13 | Lee Arnold St J | Home medical surveillance system |
EP0243588B1 (en) | 1986-02-04 | 1992-12-30 | Colin Electronics Co., Ltd. | Living body information recorder |
JPH0743748B2 (en) | 1986-02-17 | 1995-05-15 | 株式会社オークネット | Information transmission processing method of auction information transmission processing system |
US4926255A (en) | 1986-03-10 | 1990-05-15 | Kohorn H Von | System for evaluation of response to broadcast transmissions |
US5128752A (en) | 1986-03-10 | 1992-07-07 | Kohorn H Von | System and method for generating and redeeming tokens |
US5227874A (en) | 1986-03-10 | 1993-07-13 | Kohorn H Von | Method for measuring the effectiveness of stimuli on decisions of shoppers |
US4731726A (en) | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
US4738451A (en) | 1986-05-20 | 1988-04-19 | Atari Games Corporation | Multi-player, multi-character cooperative play video game with independent player entry and departure |
US4803625A (en) | 1986-06-30 | 1989-02-07 | Buddy Systems, Inc. | Personal health monitor |
US4782511A (en) | 1986-07-11 | 1988-11-01 | Murex Corporation | Interactive medical laboratory specimen apparatus system |
US4768229A (en) | 1986-07-21 | 1988-08-30 | Zenith Electronics Corporation | Restrictive access control system |
JPS6332624A (en) | 1986-07-28 | 1988-02-12 | Canon Inc | Information processor |
US5059394A (en) | 1986-08-13 | 1991-10-22 | Lifescan, Inc. | Analytical device for the automated determination of analytes in fluids |
US4935346A (en) | 1986-08-13 | 1990-06-19 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
US5049487A (en) | 1986-08-13 | 1991-09-17 | Lifescan, Inc. | Automated initiation of timing of reflectance readings |
US4799199A (en) | 1986-09-18 | 1989-01-17 | Motorola, Inc. | Bus master having burst transfer mode |
US4799156A (en) | 1986-10-01 | 1989-01-17 | Strategic Processing Corporation | Interactive market management system |
US4858354A (en) | 1987-03-09 | 1989-08-22 | Gettler Lawrence H | Organization system |
US5356287A (en) | 1987-03-16 | 1994-10-18 | Mcintyre Kevin M | Simulating presence |
ES2007041A6 (en) | 1987-04-08 | 1989-06-01 | Takio Sa | An electronic apparatus for medical diagnosis. |
EP0290683A3 (en) | 1987-05-01 | 1988-12-14 | Diva Medical Systems B.V. | Diabetes management system and apparatus |
NL8701091A (en) | 1987-05-08 | 1988-12-01 | Spruyt Hillen Bv | INJECTION PEN. |
EP0310699B1 (en) | 1987-10-09 | 1991-05-08 | Hewlett-Packard GmbH | Input device |
US4858617A (en) | 1987-09-10 | 1989-08-22 | Ith, Inc. | Cardiac probe enabling use of personal computer for monitoring heart activity or the like |
US5007429A (en) | 1987-09-21 | 1991-04-16 | Pulsetrend, Inc. | Interface using 12-digit keypad for programming parameters in ambulatory blood pressure monitor |
US4796639A (en) | 1987-11-05 | 1989-01-10 | Medical Graphics Corporation | Pulmonary diagnostic system |
US5572421A (en) | 1987-12-09 | 1996-11-05 | Altman; Louis | Portable medical questionnaire presentation device |
US5025374A (en) | 1987-12-09 | 1991-06-18 | Arch Development Corp. | Portable system for choosing pre-operative patient test |
US4853521A (en) | 1987-12-28 | 1989-08-01 | Claeys Ronald W | System for verifying and recording drug administration to a patient |
US4890621A (en) | 1988-01-19 | 1990-01-02 | Northstar Research Institute, Ltd. | Continuous glucose monitoring and a system utilized therefor |
US4950264A (en) | 1988-03-31 | 1990-08-21 | The Procter & Gamble Company | Thin, flexible sanitary napkin |
GB8809115D0 (en) | 1988-04-18 | 1988-05-18 | Turner R C | Syringes |
US5142484A (en) | 1988-05-12 | 1992-08-25 | Health Tech Services Corporation | An interactive patient assistance device for storing and dispensing prescribed medication and physical device |
US4933873A (en) | 1988-05-12 | 1990-06-12 | Healthtech Services Corp. | Interactive patient assistance device |
JPH01290361A (en) | 1988-05-17 | 1989-11-22 | Canon Inc | Facsimile equipment |
GB2218831A (en) | 1988-05-17 | 1989-11-22 | Mark John Newland | Personal medical apparatus |
US4967756A (en) | 1988-06-15 | 1990-11-06 | Instromedix, Inc. | Blood pressure and heart rate monitoring method and apparatus |
US4931934A (en) | 1988-06-27 | 1990-06-05 | Snyder Thomas E | Method and system for measuring clarified intensity of emotion |
US5204670A (en) | 1988-08-29 | 1993-04-20 | B. I. Incorporated | Adaptable electric monitoring and identification system |
US4916441A (en) | 1988-09-19 | 1990-04-10 | Clinicom Incorporated | Portable handheld terminal |
GB2225637A (en) | 1988-11-03 | 1990-06-06 | Royal Free Hosp School Med | Portable apparatus for foetal monitors |
GB8825800D0 (en) | 1988-11-04 | 1988-12-07 | Baker J | Cardiac device |
US4907973A (en) | 1988-11-14 | 1990-03-13 | Hon David C | Expert system simulator for modeling realistic internal environments and performance |
US4933876A (en) | 1988-12-28 | 1990-06-12 | Vital Lasertype, Inc. | System of operating an automatic plotter |
US5111817A (en) | 1988-12-29 | 1992-05-12 | Medical Physics, Inc. | Noninvasive system and method for enhanced arterial oxygen saturation determination and arterial blood pressure monitoring |
FI111789B (en) | 1989-01-10 | 2003-09-15 | Nintendo Co Ltd | Electronic gaming apparatus with the possibility of pseudostereophonic development of sound |
FI99250C (en) | 1989-01-10 | 1997-12-29 | Nintendo Co Ltd | System for preventing unauthorized use of external memory |
US5077476A (en) | 1990-06-27 | 1991-12-31 | Futrex, Inc. | Instrument for non-invasive measurement of blood glucose |
US5068536A (en) | 1989-01-19 | 1991-11-26 | Futrex, Inc. | Method for providing custom calibration for near infrared instruments for measurement of blood glucose |
US4978303A (en) | 1989-02-06 | 1990-12-18 | Savalife, A California General Partnership | Physical acuity test device |
US4958641A (en) | 1989-03-10 | 1990-09-25 | Instromedix, Inc. | Heart data monitoring method and apparatus |
US4977899A (en) | 1989-03-10 | 1990-12-18 | Instromedix, Inc. | Heart data monitoring method and apparatus |
US5519058A (en) | 1989-03-17 | 1996-05-21 | Cedars-Sinai Medical Center | Method for treatment with dimercaptosuccinic acid (DMSA) of hypertension, diabetic neuphropathy and atherosclerosis |
US5074317A (en) | 1989-03-24 | 1991-12-24 | Bondell James A | System for treatment of enuresis |
JP2572275B2 (en) | 1989-04-18 | 1997-01-16 | 株式会社武田エンジニアリング・コンサルタント | Hemodynamic extraction device and blood pressure measurement device by hemodynamic extraction |
US4953552A (en) | 1989-04-21 | 1990-09-04 | Demarzo Arthur P | Blood glucose monitoring system |
US5649114A (en) | 1989-05-01 | 1997-07-15 | Credit Verification Corporation | Method and system for selective incentive point-of-sale marketing in response to customer shopping histories |
US5077665A (en) | 1989-05-25 | 1991-12-31 | Reuters Limited | Distributed matching system |
US5120230A (en) | 1989-05-30 | 1992-06-09 | Optical Data Corporation | Interactive method for the effective conveyance of information in the form of visual images |
US5226895A (en) | 1989-06-05 | 1993-07-13 | Eli Lilly And Company | Multiple dose injection pen |
AT393272B (en) | 1989-06-07 | 1991-09-25 | Rettenbacher Markus Dipl Ing | METHOD FOR PRODUCING EXTRUDED, DIRECTLY EXPANDED BIOPOLYMER PRODUCTS AND WOOD FIBER PANELS, PACKAGING AND INSULATING MATERIALS |
US5009645A (en) | 1989-06-12 | 1991-04-23 | Jules Silver | Syringe for dispensing measured quantities of a material |
US4899839A (en) | 1989-06-14 | 1990-02-13 | Dessertine Albert L | Compliance and patient status monitoring system and method |
US5016172A (en) | 1989-06-14 | 1991-05-14 | Ramp Comsystems, Inc. | Patient compliance and status monitoring system |
US4979509A (en) | 1989-07-19 | 1990-12-25 | Northstar Research Institute, Ltd. | Continuous glucose monitoring and a system utilized therefor |
US5035625A (en) | 1989-07-24 | 1991-07-30 | Munson Electronics, Inc. | Computer game teaching method and system |
US5050612A (en) | 1989-09-12 | 1991-09-24 | Matsumura Kenneth N | Device for computer-assisted monitoring of the body |
CA1323922C (en) | 1989-09-26 | 1993-11-02 | William Fang | Personal health monitor enclosure |
US6024281A (en) | 1989-09-27 | 2000-02-15 | Shepley; Kenneth James | Nutritional information system for shoppers |
US4978335A (en) | 1989-09-29 | 1990-12-18 | Medex, Inc. | Infusion pump with bar code input to computer |
US5036462A (en) | 1989-09-29 | 1991-07-30 | Healthtech Services Corp. | Interactive patient assistance and medication delivery systems responsive to the physical environment of the patient |
CA1317636C (en) | 1989-09-29 | 1993-05-11 | Buddy Systems, Inc. | System and method for power supply preservation in a personal health monitor |
US5084828A (en) | 1989-09-29 | 1992-01-28 | Healthtech Services Corp. | Interactive medication delivery system |
US5065315A (en) | 1989-10-24 | 1991-11-12 | Garcia Angela M | System and method for scheduling and reporting patient related services including prioritizing services |
US5111396A (en) | 1989-11-09 | 1992-05-05 | Instromedix, Inc. | Portable ecg data-storage apparatus |
US5642731A (en) | 1990-01-17 | 1997-07-01 | Informedix, Inc. | Method of and apparatus for monitoring the management of disease |
US5176502A (en) | 1990-04-25 | 1993-01-05 | Becton, Dickinson And Company | Syringe pump and the like for delivering medication |
CH680665A5 (en) | 1990-05-11 | 1992-10-15 | Menziken Automation | |
US5171977A (en) | 1990-05-14 | 1992-12-15 | Sunquest Information Systems, Inc. | Portable medical specimen data collection system |
JP2627208B2 (en) | 1990-06-14 | 1997-07-02 | 株式会社セガ・エンタープライゼス | Game device and television tuner cartridge for game device |
US5265888A (en) | 1990-06-22 | 1993-11-30 | Nintendo Co., Ltd. | Game apparatus and memory cartridge used therefor |
JP2921936B2 (en) | 1990-07-13 | 1999-07-19 | 株式会社東芝 | Image monitoring device |
JPH0820412B2 (en) | 1990-07-20 | 1996-03-04 | 松下電器産業株式会社 | Quantitative analysis method and device using disposable sensor |
US5182707A (en) | 1990-07-23 | 1993-01-26 | Healthdyne, Inc. | Apparatus for recording reagent test strip data by comparison to color lights on a reference panel |
US5822544A (en) | 1990-07-27 | 1998-10-13 | Executone Information Systems, Inc. | Patient care and communication system |
US5120421A (en) | 1990-08-31 | 1992-06-09 | The United States Of America As Represented By The United States Department Of Energy | Electrochemical sensor/detector system and method |
US5680590A (en) | 1990-09-21 | 1997-10-21 | Parti; Michael | Simulation system and method of using same |
US5251126A (en) | 1990-10-29 | 1993-10-05 | Miles Inc. | Diabetes data analysis and interpretation method |
US5243515A (en) | 1990-10-30 | 1993-09-07 | Lee Wayne M | Secure teleprocessing bidding system |
US5143378A (en) | 1991-01-15 | 1992-09-01 | Joel Deborah L | Health game |
US5142358A (en) | 1991-02-11 | 1992-08-25 | Jason Leonard A | Earn per view television viewing regulation device |
US5230629A (en) | 1991-03-01 | 1993-07-27 | Albert Einstein College Of Medicine Of Yeshiva University | Device and method for assessing cognitive speed |
US5431690A (en) | 1991-03-18 | 1995-07-11 | Biotronik Mess- Und Therapiegerate Gmbh & Co. Ingenieurburo Berlin | Medical device for generating a therapeutic parameter |
DE4138702A1 (en) | 1991-03-22 | 1992-09-24 | Madaus Medizin Elektronik | METHOD AND DEVICE FOR THE DIAGNOSIS AND QUANTITATIVE ANALYSIS OF APNOE AND FOR THE SIMULTANEOUS DETERMINATION OF OTHER DISEASES |
US5321009A (en) | 1991-04-03 | 1994-06-14 | American Home Products Corporation | Method of treating diabetes |
US5301105A (en) | 1991-04-08 | 1994-04-05 | Desmond D. Cummings | All care health management system |
US5228450A (en) | 1991-05-03 | 1993-07-20 | Diagnostic Medical Instruments, Inc. | Methods and apparatus for ambulatory physiological monitoring |
US5335338A (en) | 1991-05-31 | 1994-08-02 | Micro Solutions, Inc. | General purpose parallel port interface |
DE4123348A1 (en) | 1991-07-15 | 1993-01-21 | Boehringer Mannheim Gmbh | ELECTROCHEMICAL ANALYSIS SYSTEM |
US6055487A (en) | 1991-07-30 | 2000-04-25 | Margery; Keith S. | Interactive remote sample analysis system |
US5366896A (en) | 1991-07-30 | 1994-11-22 | University Of Virginia Alumni Patents Foundation | Robotically operated laboratory system |
US5333981A (en) | 1991-08-26 | 1994-08-02 | Normand Pronovost | Bale loading, transporting and unloading trailer |
US5295491A (en) | 1991-09-26 | 1994-03-22 | Sam Technology, Inc. | Non-invasive human neurocognitive performance capability testing method and system |
US5504519A (en) | 1991-10-03 | 1996-04-02 | Viscorp | Method and apparatus for printing coupons and the like |
US5262943A (en) | 1991-10-15 | 1993-11-16 | National Computer Systems, Inc. | System and process for information management and reporting |
US5304112A (en) | 1991-10-16 | 1994-04-19 | Theresia A. Mrklas | Stress reduction system and method |
US5635532A (en) | 1991-10-21 | 1997-06-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia |
US5343239A (en) | 1991-11-20 | 1994-08-30 | Zing Systems, L.P. | Transaction based interactive television system |
US5734413A (en) | 1991-11-20 | 1998-03-31 | Thomson Multimedia S.A. | Transaction based interactive television system |
US5519433A (en) | 1991-11-20 | 1996-05-21 | Zing Systems, L.P. | Interactive television security through transaction time stamping |
US5353793A (en) | 1991-11-25 | 1994-10-11 | Oishi-Kogyo Company | Sensor apparatus |
JPH05168013A (en) | 1991-12-16 | 1993-07-02 | Matsushita Electric Ind Co Ltd | System for medical treatment at home |
US5467269A (en) | 1991-12-20 | 1995-11-14 | J. B. Laughrey, Inc. | Method and means for telephonically crediting customers with rebates and refunds |
US5903454A (en) | 1991-12-23 | 1999-05-11 | Hoffberg; Linda Irene | Human-factored interface corporating adaptive pattern recognition based controller apparatus |
US5289824A (en) | 1991-12-26 | 1994-03-01 | Instromedix, Inc. | Wrist-worn ECG monitor |
US5502726A (en) | 1992-01-31 | 1996-03-26 | Nellcor Incorporated | Serial layered medical network |
US5502636A (en) | 1992-01-31 | 1996-03-26 | R.R. Donnelley & Sons Company | Personalized coupon generating and processing system |
JPH08275927A (en) | 1992-02-13 | 1996-10-22 | Seta:Kk | Homestay medical care system and medical device used in this system |
JP3144030B2 (en) | 1992-02-24 | 2001-03-07 | 東陶機器株式会社 | Health management network system |
US5431691A (en) | 1992-03-02 | 1995-07-11 | Siemens Pacesetter, Inc. | Method and system for recording and displaying a sequential series of pacing events |
US5309919A (en) | 1992-03-02 | 1994-05-10 | Siemens Pacesetter, Inc. | Method and system for recording, reporting, and displaying the distribution of pacing events over time and for using same to optimize programming |
US5732696A (en) | 1992-03-17 | 1998-03-31 | New York University | Polysomnograph scoring |
US5441047A (en) | 1992-03-25 | 1995-08-15 | David; Daniel | Ambulatory patient health monitoring techniques utilizing interactive visual communication |
US5544649A (en) | 1992-03-25 | 1996-08-13 | Cardiomedix, Inc. | Ambulatory patient health monitoring techniques utilizing interactive visual communication |
US5692906A (en) | 1992-04-01 | 1997-12-02 | Corder; Paul R. | Method of diagnosing and remediating a deficiency in communications skills |
CA2088080C (en) | 1992-04-02 | 1997-10-07 | Enrico Luigi Bocchieri | Automatic speech recognizer |
AU3968793A (en) | 1992-04-02 | 1993-11-08 | United States Of America, As Represented By The Secretary Of Health And Human Services | Use of restriction endonucleases against viruses, including HIV |
US5249044A (en) | 1992-05-05 | 1993-09-28 | Kohorn H Von | Product information storage, display, and coupon dispensing system |
US5219322A (en) | 1992-06-01 | 1993-06-15 | Weathers Lawrence R | Psychotherapy apparatus and method for treating undesirable emotional arousal of a patient |
US5299121A (en) | 1992-06-04 | 1994-03-29 | Medscreen, Inc. | Non-prescription drug medication screening system |
US5390238A (en) | 1992-06-15 | 1995-02-14 | Motorola, Inc. | Health support system |
WO1994000817A1 (en) | 1992-06-22 | 1994-01-06 | Health Risk Management, Inc. | Health care management system |
US5231990A (en) | 1992-07-09 | 1993-08-03 | Spacelabs, Medical, Inc. | Application specific integrated circuit for physiological monitoring |
US5344324A (en) | 1992-07-15 | 1994-09-06 | Nova Scientific Corporation | Apparatus and method for testing human performance |
JPH0635505A (en) | 1992-07-16 | 1994-02-10 | Osayasu Sato | Automatic controller |
US5331549A (en) | 1992-07-30 | 1994-07-19 | Crawford Jr John M | Medical monitor system |
US5383858B1 (en) | 1992-08-17 | 1996-10-29 | Medrad Inc | Front-loading medical injector and syringe for use therewith |
US5951300A (en) | 1997-03-10 | 1999-09-14 | Health Hero Network | Online system and method for providing composite entertainment and health information |
US6023686A (en) | 1996-02-20 | 2000-02-08 | Health Hero Network | Method for conducting an on-line bidding session with bid pooling |
US5879163A (en) | 1996-06-24 | 1999-03-09 | Health Hero Network, Inc. | On-line health education and feedback system using motivational driver profile coding and automated content fulfillment |
US5997476A (en) | 1997-03-28 | 1999-12-07 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US5832448A (en) | 1996-10-16 | 1998-11-03 | Health Hero Network | Multiple patient monitoring system for proactive health management |
US6186145B1 (en) | 1994-05-23 | 2001-02-13 | Health Hero Network, Inc. | Method for diagnosis and treatment of psychological and emotional conditions using a microprocessor-based virtual reality simulator |
US6334778B1 (en) | 1994-04-26 | 2002-01-01 | Health Hero Network, Inc. | Remote psychological diagnosis and monitoring system |
US6167386A (en) | 1998-06-05 | 2000-12-26 | Health Hero Network, Inc. | Method for conducting an on-line bidding session with bid pooling |
US5678571A (en) | 1994-05-23 | 1997-10-21 | Raya Systems, Inc. | Method for treating medical conditions using a microprocessor-based video game |
US5956501A (en) | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
US5307263A (en) | 1992-11-17 | 1994-04-26 | Raya Systems, Inc. | Modular microprocessor-based health monitoring system |
US6101478A (en) | 1997-04-30 | 2000-08-08 | Health Hero Network | Multi-user remote health monitoring system |
US5782814A (en) | 1994-07-22 | 1998-07-21 | Raya Systems, Inc. | Apparatus for determining and recording injection doses in syringes using electrical inductance |
US5794219A (en) | 1996-02-20 | 1998-08-11 | Health Hero Network, Inc. | Method of conducting an on-line auction with bid pooling |
US5887133A (en) | 1997-01-15 | 1999-03-23 | Health Hero Network | System and method for modifying documents sent over a communications network |
US5918603A (en) | 1994-05-23 | 1999-07-06 | Health Hero Network, Inc. | Method for treating medical conditions using a microprocessor-based video game |
US5940801A (en) | 1994-04-26 | 1999-08-17 | Health Hero Network, Inc. | Modular microprocessor-based diagnostic measurement apparatus and method for psychological conditions |
US5569212A (en) | 1994-07-22 | 1996-10-29 | Raya Systems, Inc. | Apparatus for electrically determining injection doses in syringes |
US20010011224A1 (en) | 1995-06-07 | 2001-08-02 | Stephen James Brown | Modular microprocessor-based health monitoring system |
US5899855A (en) | 1992-11-17 | 1999-05-04 | Health Hero Network, Inc. | Modular microprocessor-based health monitoring system |
US5913310A (en) | 1994-05-23 | 1999-06-22 | Health Hero Network, Inc. | Method for diagnosis and treatment of psychological and emotional disorders using a microprocessor-based video game |
US5933136A (en) | 1996-12-23 | 1999-08-03 | Health Hero Network, Inc. | Network media access control system for encouraging patient compliance with a treatment plan |
US5960403A (en) | 1992-11-17 | 1999-09-28 | Health Hero Network | Health management process control system |
US5601435A (en) | 1994-11-04 | 1997-02-11 | Intercare | Method and apparatus for interactively monitoring a physiological condition and for interactively providing health related information |
US6068615A (en) | 1994-07-22 | 2000-05-30 | Health Hero Network, Inc. | Inductance-based dose measurement in syringes |
US6210272B1 (en) | 1997-12-22 | 2001-04-03 | Health Hero Network, Inc. | Multi-player interactive electronic game for health education |
US5897493A (en) | 1997-03-28 | 1999-04-27 | Health Hero Network, Inc. | Monitoring system for remotely querying individuals |
US6240393B1 (en) | 1998-06-05 | 2001-05-29 | Health Pro Network, Inc. | Aggregating and pooling weight loss information in a communication system with feedback |
US6168563B1 (en) | 1992-11-17 | 2001-01-02 | Health Hero Network, Inc. | Remote health monitoring and maintenance system |
US5371687A (en) | 1992-11-20 | 1994-12-06 | Boehringer Mannheim Corporation | Glucose test data acquisition and management system |
US5438607A (en) | 1992-11-25 | 1995-08-01 | U.S. Monitors, Ltd. | Programmable monitoring system and method |
US5590648A (en) | 1992-11-30 | 1997-01-07 | Tremont Medical | Personal health care system |
US5375604A (en) | 1992-12-11 | 1994-12-27 | Siemens Medical Electronics, Inc. | Transportable modular patient monitor |
ATE190413T1 (en) | 1992-12-11 | 2000-03-15 | Siemens Medical Systems Inc | PORTABLE MODULAR PATIENT MONITORING DEVICE WITH DATA COLLECTION MODULE |
DE69326934T2 (en) | 1992-12-16 | 2000-03-30 | Siemens Medical Systems Inc | Patient location and patient data monitoring system |
JPH06231186A (en) | 1993-02-03 | 1994-08-19 | Fujitsu Ltd | Document processor |
US5377100A (en) | 1993-03-08 | 1994-12-27 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Method of encouraging attention by correlating video game difficulty with attention level |
US5576952A (en) | 1993-03-09 | 1996-11-19 | Metriplex, Inc. | Medical alert distribution system with selective filtering of medical information |
US5357427A (en) | 1993-03-15 | 1994-10-18 | Digital Equipment Corporation | Remote monitoring of high-risk patients using artificial intelligence |
US5799318A (en) | 1993-04-13 | 1998-08-25 | Firstfloor Software | Method and apparatus for collecting and displaying information from diverse computer resources |
US5558638A (en) | 1993-04-30 | 1996-09-24 | Healthdyne, Inc. | Patient monitor and support system |
WO1994025927A2 (en) | 1993-04-30 | 1994-11-10 | Hever For Life For Health For Spirit Ltd. | Personalized method and system for storage, communication, analysis and processing of health-related data |
US5882338A (en) | 1993-05-04 | 1999-03-16 | Zeneca Limited | Syringes and syringe pumps |
US5594637A (en) | 1993-05-26 | 1997-01-14 | Base Ten Systems, Inc. | System and method for assessing medical risk |
US5501231A (en) | 1993-06-02 | 1996-03-26 | Kaish; Norman | Patient operated system for testing and recording a biological condition of the patient |
US5429140A (en) | 1993-06-04 | 1995-07-04 | Greenleaf Medical Systems, Inc. | Integrated virtual reality rehabilitation system |
US5793969A (en) | 1993-07-09 | 1998-08-11 | Neopath, Inc. | Network review and analysis of computer encoded slides |
US5410474A (en) | 1993-07-27 | 1995-04-25 | Miles Inc. | Buttonless memory system for an electronic measurement device |
US5368562A (en) | 1993-07-30 | 1994-11-29 | Pharmacia Deltec, Inc. | Systems and methods for operating ambulatory medical devices such as drug delivery devices |
US5483276A (en) | 1993-08-02 | 1996-01-09 | The Arbitron Company | Compliance incentives for audience monitoring/recording devices |
US5572646A (en) | 1993-08-25 | 1996-11-05 | Casio Computer Co., Ltd. | Apparatus for displaying images of living things to show growing and/or moving of the living things |
US5377258A (en) | 1993-08-30 | 1994-12-27 | National Medical Research Council | Method and apparatus for an automated and interactive behavioral guidance system |
US5456692A (en) | 1993-09-03 | 1995-10-10 | Pacesetter, Inc. | System and method for noninvasively altering the function of an implanted pacemaker |
US5438983A (en) | 1993-09-13 | 1995-08-08 | Hewlett-Packard Company | Patient alarm detection using trend vector analysis |
US5659691A (en) | 1993-09-23 | 1997-08-19 | Virtual Universe Corporation | Virtual reality network with selective distribution and updating of data to reduce bandwidth requirements |
US5517405A (en) | 1993-10-14 | 1996-05-14 | Aetna Life And Casualty Company | Expert system for providing interactive assistance in solving problems such as health care management |
US5399821A (en) | 1993-10-20 | 1995-03-21 | Teikoku Tsushin Kogyo Co., Ltd. | Keytop for push-button switches, and method of manufacturing same |
US5454722A (en) | 1993-11-12 | 1995-10-03 | Project Orbis International, Inc. | Interactive multimedia eye surgery training apparatus and method |
DE4339188A1 (en) | 1993-11-16 | 1995-05-18 | Mueller & Sebastiani Elek Gmbh | Portable device for recording body-specific measurement data |
EP0684575A4 (en) | 1993-12-14 | 1997-05-14 | Mochida Pharm Co Ltd | Medical measuring apparatus. |
US6022315A (en) | 1993-12-29 | 2000-02-08 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system including network access |
US5935060A (en) | 1996-07-12 | 1999-08-10 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system including list based processing |
US5724968A (en) | 1993-12-29 | 1998-03-10 | First Opinion Corporation | Computerized medical diagnostic system including meta function |
US5454721A (en) | 1993-12-30 | 1995-10-03 | Kuch; Nina J. | Application of multi-media technology to nutrition education and diet planning |
US5471382A (en) | 1994-01-10 | 1995-11-28 | Informed Access Systems, Inc. | Medical network management system and process |
US5714319A (en) | 1994-02-28 | 1998-02-03 | Institut National De La Sante Et De La Recherche Medicale | Method for the screening of familial hemiplegic migraine (FHM) |
US5536249A (en) | 1994-03-09 | 1996-07-16 | Visionary Medical Products, Inc. | Pen-type injector with a microprocessor and blood characteristic monitor |
US5449334A (en) | 1994-03-22 | 1995-09-12 | Kingsbury; Doug | Rotatable exercise apparatus |
US5488412A (en) | 1994-03-31 | 1996-01-30 | At&T Corp. | Customer premises equipment receives high-speed downstream data over a cable television system and transmits lower speed upstream signaling on a separate channel |
EP0760138A4 (en) | 1994-04-26 | 1998-04-01 | Raya Systems Inc | Modular microprocessor-based diagnostic measurement system for psychological conditions |
US5574828A (en) | 1994-04-28 | 1996-11-12 | Tmrc | Expert system for generating guideline-based information tools |
US5550575A (en) | 1994-05-04 | 1996-08-27 | West; Brett | Viewer discretion television program control system |
US5704366A (en) | 1994-05-23 | 1998-01-06 | Enact Health Management Systems | System for monitoring and reporting medical measurements |
US5794251A (en) | 1994-06-06 | 1998-08-11 | Canon Kabushiki Kaisha | Information file processing apparatus and method |
US5518001A (en) | 1994-06-17 | 1996-05-21 | Pacesetter, Inc. | Cardiac device with patient-triggered storage of physiological sensor data |
US5471039A (en) | 1994-06-22 | 1995-11-28 | Panda Eng. Inc. | Electronic validation machine for documents |
US5624265A (en) | 1994-07-01 | 1997-04-29 | Tv Interactive Data Corporation | Printed publication remote contol for accessing interactive media |
JPH0877155A (en) | 1994-07-07 | 1996-03-22 | Sanyo Electric Co Ltd | Information processor and information processing method |
US5720733A (en) | 1994-07-22 | 1998-02-24 | Raya Systems, Inc. | Apparatus for determining and recording injection doses in syringes using electrical capacitance measurements |
US5792117A (en) | 1994-07-22 | 1998-08-11 | Raya Systems, Inc. | Apparatus for optically determining and electronically recording injection doses in syringes |
US6110148A (en) | 1994-07-22 | 2000-08-29 | Health Hero Network, Inc. | Capacitance-based dose measurements in syringes |
US5629981A (en) | 1994-07-29 | 1997-05-13 | Texas Instruments Incorporated | Information management and security system |
US5875432A (en) | 1994-08-05 | 1999-02-23 | Sehr; Richard Peter | Computerized voting information system having predefined content and voting templates |
US5593349A (en) | 1994-09-09 | 1997-01-14 | Valley Recreation Products Inc. | Automated league and tournament system for electronic games |
JPH0883271A (en) | 1994-09-09 | 1996-03-26 | Fuji Xerox Co Ltd | Document processor |
US5633910A (en) | 1994-09-13 | 1997-05-27 | Cohen; Kopel H. | Outpatient monitoring system |
AUPM813394A0 (en) | 1994-09-14 | 1994-10-06 | Dolphin Software Pty Ltd | A method and apparatus for preparation of a database document in a local processing apparatus and loading of the database document with data from remote sources |
US5687734A (en) | 1994-10-20 | 1997-11-18 | Hewlett-Packard Company | Flexible patient monitoring system featuring a multiport transmitter |
US5628004A (en) | 1994-11-04 | 1997-05-06 | Optima Direct, Inc. | System for managing database of communication of recipients |
US5827180A (en) | 1994-11-07 | 1998-10-27 | Lifemasters Supported Selfcare | Method and apparatus for a personal health network |
JP2840923B2 (en) | 1994-11-11 | 1998-12-24 | 富士通株式会社 | Production system |
US5488423A (en) | 1994-11-17 | 1996-01-30 | U.S. Narrow Networks, Inc. | Home communication method and apparatus |
US5546943A (en) | 1994-12-09 | 1996-08-20 | Gould; Duncan K. | Stimulating a beneficial human response by using visualization of medical scan data to achieve psychoneuroimmunological virtual reality |
US5717913A (en) | 1995-01-03 | 1998-02-10 | University Of Central Florida | Method for detecting and extracting text data using database schemas |
US5553609A (en) | 1995-02-09 | 1996-09-10 | Visiting Nurse Service, Inc. | Intelligent remote visual monitoring system for home health care service |
US5778882A (en) | 1995-02-24 | 1998-07-14 | Brigham And Women's Hospital | Health monitoring system |
US5640953A (en) | 1995-03-09 | 1997-06-24 | Siemens Medical Systems, Inc. | Portable patient monitor reconfiguration system |
US5619991A (en) | 1995-04-26 | 1997-04-15 | Lucent Technologies Inc. | Delivery of medical services using electronic data communications |
US5689652A (en) | 1995-04-27 | 1997-11-18 | Optimark Technologies, Inc. | Crossing network utilizing optimal mutual satisfaction density profile |
US5640569A (en) | 1995-04-28 | 1997-06-17 | Sun Microsystems, Inc. | Diverse goods arbitration system and method for allocating resources in a distributed computer system |
US5727153A (en) | 1995-06-06 | 1998-03-10 | Powell; Ken R. | Retail store having a system of receiving electronic coupon information from a portable card and sending the received coupon information to other portable cards |
US5710918A (en) | 1995-06-07 | 1998-01-20 | International Business Machines Corporation | Method for distributed task fulfillment of web browser requests |
US5666487A (en) | 1995-06-28 | 1997-09-09 | Bell Atlantic Network Services, Inc. | Network providing signals of different formats to a user by multplexing compressed broadband data with data of a different format into MPEG encoded data stream |
US5651775A (en) | 1995-07-12 | 1997-07-29 | Walker; Richard Bradley | Medication delivery and monitoring system and methods |
US5715451A (en) | 1995-07-20 | 1998-02-03 | Spacelabs Medical, Inc. | Method and system for constructing formulae for processing medical data |
US6001065A (en) | 1995-08-02 | 1999-12-14 | Ibva Technologies, Inc. | Method and apparatus for measuring and analyzing physiological signals for active or passive control of physical and virtual spaces and the contents therein |
JPH0947436A (en) | 1995-08-09 | 1997-02-18 | Noboru Akasaka | Home medical system |
US5752234A (en) | 1995-08-18 | 1998-05-12 | Patient Solutions | Method and apparatus for managing disposable medical supplies appropriate for a single patient visit |
US5893077A (en) | 1995-08-23 | 1999-04-06 | Microsoft Corporation | Method and apparatus for generating and collecting a billing event object within an on-line network |
US5704902A (en) | 1995-09-19 | 1998-01-06 | Headwaters Research & Development Inc | Handholdable massager having combination massaging and dual function two speed actuator pad |
US6177940B1 (en) | 1995-09-20 | 2001-01-23 | Cedaron Medical, Inc. | Outcomes profile management system for evaluating treatment effectiveness |
US5961446A (en) | 1995-10-06 | 1999-10-05 | Tevital Incorporated | Patient terminal for home health care system |
US5717739A (en) | 1995-10-13 | 1998-02-10 | Dyer; Dwayne | Methods and apparatus for enabling an operator to provide pre-recorded information to a customer |
US6436036B1 (en) | 1995-11-01 | 2002-08-20 | Weight Watchers (Uk) Limited | Process for controlling body weight |
US5679075A (en) | 1995-11-06 | 1997-10-21 | Beanstalk Entertainment Enterprises | Interactive multi-media game system and method |
US5704364A (en) | 1995-11-08 | 1998-01-06 | Instromedix, Inc. | Concurrent medical patient data and voice communication method and apparatus |
US5678562A (en) | 1995-11-09 | 1997-10-21 | Burdick, Inc. | Ambulatory physiological monitor with removable disk cartridge and wireless modem |
JP3493847B2 (en) | 1995-11-15 | 2004-02-03 | 株式会社日立製作所 | Wide-area medical information system |
US5730654A (en) | 1995-12-18 | 1998-03-24 | Raya Systems, Inc. | Multi-player video game for health education |
US5675635A (en) | 1996-01-24 | 1997-10-07 | Sprint Communications Company L.P. | System and method for conducting poll at a processor associated with the originating switch |
US5628309A (en) | 1996-01-25 | 1997-05-13 | Raya Systems, Inc. | Meter for electrically measuring and recording injection syringe doses |
US5704922A (en) | 1996-01-25 | 1998-01-06 | Raya Systems, Inc. | Syringe having electrical contact points for metering doses |
US5642936A (en) | 1996-01-29 | 1997-07-01 | Oncormed | Methods for identifying human hereditary disease patterns |
US6678669B2 (en) * | 1996-02-09 | 2004-01-13 | Adeza Biomedical Corporation | Method for selecting medical and biochemical diagnostic tests using neural network-related applications |
FI118509B (en) | 1996-02-12 | 2007-12-14 | Nokia Oyj | A method and apparatus for predicting blood glucose levels in a patient |
US5651363A (en) | 1996-02-16 | 1997-07-29 | Orthologic Corporation | Ultrasonic bone assessment method and apparatus |
US5715823A (en) | 1996-02-27 | 1998-02-10 | Atlantis Diagnostics International, L.L.C. | Ultrasonic diagnostic imaging system with universal access to diagnostic information and images |
US5670711A (en) | 1996-03-08 | 1997-09-23 | Regents Of The University Of Minnesota | Portable rock strength evaluation device |
US6055314A (en) | 1996-03-22 | 2000-04-25 | Microsoft Corporation | System and method for secure purchase and delivery of video content programs |
US5680866A (en) | 1996-03-29 | 1997-10-28 | Battelle Memorial Institute | Artificial neural network cardiopulmonary modeling and diagnosis |
US5835896A (en) | 1996-03-29 | 1998-11-10 | Onsale, Inc. | Method and system for processing and transmitting electronic auction information |
US5801755A (en) | 1996-04-09 | 1998-09-01 | Echerer; Scott J. | Interactive communciation system for medical treatment of remotely located patients |
US5842976A (en) | 1996-05-16 | 1998-12-01 | Pyxis Corporation | Dispensing, storage, control and inventory system with medication and treatment chart record |
US6108635A (en) * | 1996-05-22 | 2000-08-22 | Interleukin Genetics, Inc. | Integrated disease information system |
US6050940A (en) | 1996-06-17 | 2000-04-18 | Cybernet Systems Corporation | General-purpose medical instrumentation |
US5825283A (en) | 1996-07-03 | 1998-10-20 | Camhi; Elie | System for the security and auditing of persons and property |
US5760771A (en) | 1996-07-17 | 1998-06-02 | At & T Corp | System and method for providing structured tours of hypertext files |
US5687717A (en) | 1996-08-06 | 1997-11-18 | Tremont Medical, Inc. | Patient monitoring system with chassis mounted or remotely operable modules and portable computer |
US5819735A (en) | 1996-08-15 | 1998-10-13 | Mansfield; Elizabeth A. | Device and method for monitoring dietary intake of calories and nutrients |
US5810747A (en) | 1996-08-21 | 1998-09-22 | Interactive Remote Site Technology, Inc. | Remote site medical intervention system |
US5772585A (en) | 1996-08-30 | 1998-06-30 | Emc, Inc | System and method for managing patient medical records |
US5791342A (en) | 1996-09-03 | 1998-08-11 | Telediagnostics Systems, Inc. | Medical data transmission system |
US6189029B1 (en) | 1996-09-20 | 2001-02-13 | Silicon Graphics, Inc. | Web survey tool builder and result compiler |
US5800458A (en) | 1996-09-30 | 1998-09-01 | Rehabilicare, Inc. | Compliance monitor for monitoring applied electrical stimulation |
US5954641A (en) | 1997-09-08 | 1999-09-21 | Informedix, Inc. | Method, apparatus and operating system for managing the administration of medication and medical treatment regimens |
US5796393A (en) | 1996-11-08 | 1998-08-18 | Compuserve Incorporated | System for intergrating an on-line service community with a foreign service |
US5983003A (en) | 1996-11-15 | 1999-11-09 | International Business Machines Corp. | Interactive station indicator and user qualifier for virtual worlds |
US5950630A (en) * | 1996-12-12 | 1999-09-14 | Portwood; Michael T. | System and method for improving compliance of a medical regimen |
US6151586A (en) | 1996-12-23 | 2000-11-21 | Health Hero Network, Inc. | Computerized reward system for encouraging participation in a health management program |
US6032119A (en) | 1997-01-16 | 2000-02-29 | Health Hero Network, Inc. | Personalized display of health information |
DE19707026B4 (en) | 1997-02-21 | 2004-10-28 | Siemens Ag | Medical therapy and / or diagnostic system |
JP3044116U (en) | 1997-03-18 | 1997-12-16 | 株式会社バンダイ | Virtual life training simulator |
US5983217A (en) | 1997-03-21 | 1999-11-09 | At&T Corp | Apparatus and method for querying replicated databases |
US6270455B1 (en) | 1997-03-28 | 2001-08-07 | Health Hero Network, Inc. | Networked system for interactive communications and remote monitoring of drug delivery |
US6055506A (en) | 1997-04-25 | 2000-04-25 | Unitron Medical Communications, Inc. | Outpatient care data system |
US6248065B1 (en) | 1997-04-30 | 2001-06-19 | Health Hero Network, Inc. | Monitoring system for remotely querying individuals |
JP3012560B2 (en) | 1997-06-25 | 2000-02-21 | 日本電気ソフトウェア株式会社 | Computer-based electronic dialogue method, computer-to-computer electronic dialogue device, and computer-readable recording medium recording computer-based electronic dialogue program |
US5945651A (en) | 1997-07-17 | 1999-08-31 | Chorosinski; Leonard | Remotely programmable medication dispensing system |
US6370513B1 (en) | 1997-08-08 | 2002-04-09 | Parasoft Corporation | Method and apparatus for automated selection, organization, and recommendation of items |
US6029138A (en) | 1997-08-15 | 2000-02-22 | Brigham And Women's Hospital | Computer system for decision support in the selection of diagnostic and therapeutic tests and interventions for patients |
US5971855A (en) | 1997-09-30 | 1999-10-26 | Tiger Electronics, Ltd. | Apparatus and method of communicating between electronic games |
KR100269258B1 (en) | 1997-10-21 | 2000-10-16 | 정선종 | Integrated CASE Information Repository Metamodel System for Process Methodology and its Integration Support Method |
US5868683A (en) | 1997-10-24 | 1999-02-09 | Scientific Learning Corporation | Techniques for predicting reading deficit based on acoustical measurements |
US5987471A (en) | 1997-11-13 | 1999-11-16 | Novell, Inc. | Sub-foldering system in a directory-service-based launcher |
US6049794A (en) | 1997-12-09 | 2000-04-11 | Jacobs; Charles M. | System for screening of medical decision making incorporating a knowledge base |
JPH11296598A (en) | 1998-04-07 | 1999-10-29 | Seizaburo Arita | System and method for predicting blood-sugar level and record medium where same method is recorded |
US6057758A (en) | 1998-05-20 | 2000-05-02 | Hewlett-Packard Company | Handheld clinical terminal |
US6161095A (en) | 1998-12-16 | 2000-12-12 | Health Hero Network, Inc. | Treatment regimen compliance and efficacy with feedback |
US6513532B2 (en) | 2000-01-19 | 2003-02-04 | Healthetech, Inc. | Diet and activity-monitoring device |
USD439242S1 (en) | 2000-03-24 | 2001-03-20 | Health Hero Network, Inc. | Information appliance |
US20030068649A1 (en) * | 2000-09-14 | 2003-04-10 | Doberstein Stephen K. | Methods and compositions for the construction and use of fusion libraries |
-
2000
- 2000-02-02 US US09/496,893 patent/US8078407B1/en not_active Expired - Fee Related
-
2006
- 2006-02-23 US US11/359,437 patent/US20060200319A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5660176A (en) * | 1993-12-29 | 1997-08-26 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system |
US6329139B1 (en) * | 1995-04-25 | 2001-12-11 | Discovery Partners International | Automated sorting system for matrices with memory |
Cited By (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8458121B2 (en) | 2007-03-16 | 2013-06-04 | Expanse Networks, Inc. | Predisposition prediction using attribute combinations |
US20080228722A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Attribute Prediction Using Attribute Combinations |
US20080228706A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Determining Bioattribute Associations Using Expanded Bioattribute Profiles |
US20080228824A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Treatment Determination and Impact Analysis |
US20080228756A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Compiling Co-associating Bioattributes |
US20080227063A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc | Career Selection and Psychological Profiling |
US20080228698A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Creation of Attribute Combination Databases |
US20080228757A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Identifying Co-associating Bioattributes |
US20080228531A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Insurance Optimization and Longevity Analysis |
US20080228699A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Creation of Attribute Combination Databases |
US20080228451A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Predisposition Prediction Using Co-associating Bioattributes |
US8655908B2 (en) | 2007-03-16 | 2014-02-18 | Expanse Bioinformatics, Inc. | Predisposition modification |
US20080228708A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Goal Achievement and Outcome Prevention |
US20080228751A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Attribute Combination Discovery |
US20080228818A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Compiling Co-associating Bioattributes |
US20080228704A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Expanding Bioattribute Profiles |
US20080228766A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Efficiently Compiling Co-associating Attributes |
US20080228677A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Identifying Co-associating Bioattributes |
US20080228727A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Predisposition Modification |
US20080228410A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Genetic attribute analysis |
US20080228730A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Compiling Co-associating Bioattributes Using Expanded Bioattribute Profiles |
US20080228765A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Genetic Attribute Analysis |
US20080228700A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Attribute Combination Discovery |
US20080228701A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Destiny Modification Using Attribute Combinations |
US20080228043A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Diagnosis Determination and Strength and Weakness Analysis |
US20080228702A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Predisposition Modification Using Attribute Combinations |
US20080228820A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Efficiently Compiling Co-associating Bioattributes |
US8606761B2 (en) | 2007-03-16 | 2013-12-10 | Expanse Bioinformatics, Inc. | Lifestyle optimization and behavior modification |
US7797302B2 (en) | 2007-03-16 | 2010-09-14 | Expanse Networks, Inc. | Compiling co-associating bioattributes |
US7818310B2 (en) | 2007-03-16 | 2010-10-19 | Expanse Networks, Inc. | Predisposition modification |
US7844609B2 (en) | 2007-03-16 | 2010-11-30 | Expanse Networks, Inc. | Attribute combination discovery |
US7933912B2 (en) | 2007-03-16 | 2011-04-26 | Expanse Networks, Inc. | Compiling co-associating bioattributes using expanded bioattribute profiles |
US7941434B2 (en) | 2007-03-16 | 2011-05-10 | Expanse Networks, Inc. | Efficiently compiling co-associating bioattributes |
US7941329B2 (en) | 2007-03-16 | 2011-05-10 | Expanse Networks, Inc. | Insurance optimization and longevity analysis |
US8024348B2 (en) | 2007-03-16 | 2011-09-20 | Expanse Networks, Inc. | Expanding attribute profiles |
US8051033B2 (en) | 2007-03-16 | 2011-11-01 | Expanse Networks, Inc. | Predisposition prediction using attribute combinations |
US8055643B2 (en) | 2007-03-16 | 2011-11-08 | Expanse Networks, Inc. | Predisposition modification |
US8065324B2 (en) | 2007-03-16 | 2011-11-22 | Expanse Networks, Inc. | Weight and diet attribute combination discovery |
US8099424B2 (en) | 2007-03-16 | 2012-01-17 | Expanse Networks, Inc. | Treatment determination and impact analysis |
US8185461B2 (en) | 2007-03-16 | 2012-05-22 | Expanse Networks, Inc. | Longevity analysis and modifiable attribute identification |
US8209319B2 (en) | 2007-03-16 | 2012-06-26 | Expanse Networks, Inc. | Compiling co-associating bioattributes |
US8224835B2 (en) | 2007-03-16 | 2012-07-17 | Expanse Networks, Inc. | Expanding attribute profiles |
US11791054B2 (en) | 2007-03-16 | 2023-10-17 | 23Andme, Inc. | Comparison and identification of attribute similarity based on genetic markers |
US20080243843A1 (en) * | 2007-03-16 | 2008-10-02 | Expanse Networks, Inc. | Predisposition Modification Using Co-associating Bioattributes |
US20080228753A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Determining Attribute Associations Using Expanded Attribute Profiles |
US8655899B2 (en) | 2007-03-16 | 2014-02-18 | Expanse Bioinformatics, Inc. | Attribute method and system |
US11735323B2 (en) | 2007-03-16 | 2023-08-22 | 23Andme, Inc. | Computer implemented identification of genetic similarity |
US20080228703A1 (en) * | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Expanding Attribute Profiles |
US8788283B2 (en) | 2007-03-16 | 2014-07-22 | Expanse Bioinformatics, Inc. | Modifiable attribute identification |
US11621089B2 (en) | 2007-03-16 | 2023-04-04 | 23Andme, Inc. | Attribute combination discovery for predisposition determination of health conditions |
US11600393B2 (en) | 2007-03-16 | 2023-03-07 | 23Andme, Inc. | Computer implemented modeling and prediction of phenotypes |
US11581096B2 (en) | 2007-03-16 | 2023-02-14 | 23Andme, Inc. | Attribute identification based on seeded learning |
US11581098B2 (en) | 2007-03-16 | 2023-02-14 | 23Andme, Inc. | Computer implemented predisposition prediction in a genetics platform |
US9170992B2 (en) | 2007-03-16 | 2015-10-27 | Expanse Bioinformatics, Inc. | Treatment determination and impact analysis |
US9582647B2 (en) | 2007-03-16 | 2017-02-28 | Expanse Bioinformatics, Inc. | Attribute combination discovery for predisposition determination |
US11545269B2 (en) | 2007-03-16 | 2023-01-03 | 23Andme, Inc. | Computer implemented identification of genetic similarity |
US11515047B2 (en) | 2007-03-16 | 2022-11-29 | 23Andme, Inc. | Computer implemented identification of modifiable attributes associated with phenotypic predispositions in a genetics platform |
US11495360B2 (en) | 2007-03-16 | 2022-11-08 | 23Andme, Inc. | Computer implemented identification of treatments for predicted predispositions with clinician assistance |
US11482340B1 (en) | 2007-03-16 | 2022-10-25 | 23Andme, Inc. | Attribute combination discovery for predisposition determination of health conditions |
US11348692B1 (en) | 2007-03-16 | 2022-05-31 | 23Andme, Inc. | Computer implemented identification of modifiable attributes associated with phenotypic predispositions in a genetics platform |
US10379812B2 (en) | 2007-03-16 | 2019-08-13 | Expanse Bioinformatics, Inc. | Treatment determination and impact analysis |
US10803134B2 (en) | 2007-03-16 | 2020-10-13 | Expanse Bioinformatics, Inc. | Computer implemented identification of genetic similarity |
US10896233B2 (en) | 2007-03-16 | 2021-01-19 | Expanse Bioinformatics, Inc. | Computer implemented identification of genetic similarity |
US10957455B2 (en) | 2007-03-16 | 2021-03-23 | Expanse Bioinformatics, Inc. | Computer implemented identification of genetic similarity |
US10991467B2 (en) | 2007-03-16 | 2021-04-27 | Expanse Bioinformatics, Inc. | Treatment determination and impact analysis |
US11348691B1 (en) | 2007-03-16 | 2022-05-31 | 23Andme, Inc. | Computer implemented predisposition prediction in a genetics platform |
US20090043752A1 (en) * | 2007-08-08 | 2009-02-12 | Expanse Networks, Inc. | Predicting Side Effect Attributes |
US8788286B2 (en) | 2007-08-08 | 2014-07-22 | Expanse Bioinformatics, Inc. | Side effects prediction using co-associating bioattributes |
US9031870B2 (en) | 2008-12-30 | 2015-05-12 | Expanse Bioinformatics, Inc. | Pangenetic web user behavior prediction system |
US11514085B2 (en) | 2008-12-30 | 2022-11-29 | 23Andme, Inc. | Learning system for pangenetic-based recommendations |
US11003694B2 (en) | 2008-12-30 | 2021-05-11 | Expanse Bioinformatics | Learning systems for pangenetic-based recommendations |
US8655915B2 (en) | 2008-12-30 | 2014-02-18 | Expanse Bioinformatics, Inc. | Pangenetic web item recommendation system |
US11935628B2 (en) | 2008-12-31 | 2024-03-19 | 23Andme, Inc. | Finding relatives in a database |
US11657902B2 (en) | 2008-12-31 | 2023-05-23 | 23Andme, Inc. | Finding relatives in a database |
US11468971B2 (en) | 2008-12-31 | 2022-10-11 | 23Andme, Inc. | Ancestry finder |
US11322227B2 (en) | 2008-12-31 | 2022-05-03 | 23Andme, Inc. | Finding relatives in a database |
US11776662B2 (en) | 2008-12-31 | 2023-10-03 | 23Andme, Inc. | Finding relatives in a database |
US11508461B2 (en) | 2008-12-31 | 2022-11-22 | 23Andme, Inc. | Finding relatives in a database |
US10074148B2 (en) | 2011-03-31 | 2018-09-11 | Rite Aid Hdqtrs. Corp. | Medical kiosk and method of use |
US8996392B2 (en) | 2011-03-31 | 2015-03-31 | Healthspot, Inc. | Medical kiosk and method of use |
US9043217B2 (en) | 2011-03-31 | 2015-05-26 | HealthSpot Inc. | Medical kiosk and method of use |
CN102831097A (en) * | 2011-05-27 | 2012-12-19 | 感芯科股份有限公司 | Cloud server for collecting physiological state information and observation system thereof |
USD694909S1 (en) | 2011-10-12 | 2013-12-03 | HealthSpot Inc. | Medical kiosk |
US10223681B2 (en) | 2012-08-15 | 2019-03-05 | Rite Aid Hdqtrs. Corp. | Veterinary kiosk with integrated veterinary medical devices |
US20170214750A1 (en) * | 2016-01-21 | 2017-07-27 | Horiba, Ltd. | Management apparatus for measurement equipment |
US11410745B2 (en) * | 2018-06-18 | 2022-08-09 | International Business Machines Corporation | Determining potential cancer therapeutic targets by joint modeling of survival events |
Also Published As
Publication number | Publication date |
---|---|
US8078407B1 (en) | 2011-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20120130647A1 (en) | System and method for identifying disease-influencing genes | |
US20060200319A1 (en) | System and method for identifying disease-influencing genes | |
US8693751B2 (en) | Artificial intelligence system for genetic analysis | |
JP5966109B1 (en) | Artificial intelligence system for gene analysis | |
US8571810B2 (en) | Information processing system using nucleotide sequence-related information | |
AU784645B2 (en) | Method for providing clinical diagnostic services | |
US20020082869A1 (en) | Method and system for providing and updating customized health care information based on an individual's genome | |
CA2459003A1 (en) | Method and system for data evaluation, corresponding computer program product, and corresponding computer-readable storage medium | |
US20030113756A1 (en) | Methods of providing customized gene annotation reports | |
MXPA04002684A (en) | Systems, methods and kits for remote genetic analysis and consultation. | |
JP2004348749A (en) | Medical information system, system and method for providing medical information, and gene analysis system | |
EP1111525A2 (en) | A method of guaranteeing the quality of a product with biotechnology and a method of delivering gene information | |
EP1598765A1 (en) | Information processing system using base sequence relevant information | |
EP1569154A1 (en) | Data processing system using base sequence-relating data | |
WO2002037940A2 (en) | System and method for biological sample analysis and adaptive diagnostic device creation | |
Legacy | On the Shoulders of Giants: Private Sector Leverages HGP Successes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |